Cholecystitis is an inflammation of the gallbladder and/or the biliary tract. Acute cholecystitis typically causes pain, tenderness, and rigidity in the upper right abdomen, which may radiate to the midsternal area or right shoulder.

Calculous Cholecystitis (90% of cases): This is the most common type. The inflammation is caused by a gallstone obstructing the cystic duct, leading to bile stasis. The trapped bile acts as a chemical irritant, resulting in inflammation, edema, and potential compromise of the vascular supply, which can lead to gangrene.
Acalculous Cholecystitis: This describes acute gallbladder inflammation that occurs in the absence of obstruction by gallstones. It typically occurs in critically ill patients after major surgery, severe trauma, or burns.

Causes

Obstruction of the cystic duct by gallstones (most common cause).
Major abdominal trauma or severe burns.
Major surgery (especially abdominal surgery).
Multiple blood transfusions.
Primary bacterial infections of the gallbladder (e.g., from E. coli, Klebsiella).

Clinical Features of Cholecystitis

Pain and Biliary Colic: The hallmark symptom is excruciating pain in the upper right quadrant (RUQ) of the abdomen, which can be constant or colicky (cramping). The pain often radiates to the back or right shoulder. The pain may also be exacerbated by deep breathing or palpation of the RUQ.

Abdominal Signs: Marked tenderness and rigidity in the RUQ. A palpable abdominal mass may be felt due to an inflamed and distended gallbladder. A positive Murphy's sign (inspiratory arrest upon deep RUQ palpation while the patient takes a deep breath) is a classic finding, indicating inflammation of the gallbladder.

Gastrointestinal Symptoms: Nausea and vomiting are common, especially after a heavy or fatty meal, as the gallbladder is stimulated to contract to release bile, exacerbating the obstruction. Anorexia may also be present.

Systemic Signs: Fever (38–39°C) with chills indicates an inflammatory response and potential infection. Tachycardia (increased heart rate) may also be present.

Signs of Biliary Obstruction: These signs suggest that the obstruction extends beyond the cystic duct to the common bile duct.

Jaundice: Yellow discoloration of the skin and sclera due to the buildup of bilirubin if a stone obstructs the common bile duct.
Changes in Urine and Stool: Very dark urine (due to bilirubin excretion in urine) and clay-colored stools (due to lack of bilirubin in stool) are indicative of complete bile duct obstruction.
Severe Pruritus (itching): Due to bile salt deposition in the skin.
Vitamin Deficiency: Impaired bile flow can lead to poor absorption of fat-soluble vitamins (A, D, E, and K), which can manifest as night blindness (A), bone problems (D), neurological issues (E), and bleeding tendencies (K).

Classification of Acute Cholecystitis

The severity is classified into three grades to guide treatment and prognosis (Tokyo Guidelines 2018):

Grade I (Mild): The inflammation is limited to the gallbladder with no associated organ dysfunction. This typically resolves with conservative management.

Grade II (Moderate): Associated with more extensive disease in the gallbladder, but still no organ dysfunction. Criteria include:

Elevated white blood cell count (WBC > 18,000/mm³)
Palpable tender mass in the RUQ
Duration of symptoms > 72 hours
Evidence of local inflammation (e.g., pericholecystic fluid, localized peritonitis, phlegmonous cholecystitis on imaging)

Grade III (Severe): An acute phase associated with organ dysfunction (e.g., cardiovascular, renal, respiratory, or hepatic failure, or central nervous system dysfunction). This indicates a systemic inflammatory response and requires urgent intervention.

Investigations

Abdominal Ultrasound: This is the primary imaging test due to its non-invasiveness, availability, and cost-effectiveness. It reveals gallbladder wall thickening (>4 mm), the presence of gallstones within the lumen, pericholecystic fluid (fluid around the gallbladder), and a positive sonographic Murphy's sign.

Complete Blood Count (CBC): To check for an elevated white blood cell count (leukocytosis, typically >10,000/mm³), indicating infection and inflammation.

Liver and Renal Function Tests:

Liver Function Tests (LFTs): Elevated bilirubin, alkaline phosphatase, ALT, and AST may indicate biliary obstruction (cholestasis) or liver involvement.
Renal Function Tests: Urea, creatinine, and electrolytes are monitored to assess kidney function, especially in critically ill patients or those with dehydration.

Pancreatic Enzymes: Serum amylase and lipase levels are checked to rule out pancreatitis, a common and serious complication if a gallstone obstructs the pancreatic duct.

Abdominal X-ray: While not the primary diagnostic tool for cholecystitis, it may occasionally show calcified gallstones (though most gallstones are radiolucent) or rule out other causes of abdominal pain (e.g., bowel obstruction, free air).

Hepatobiliary Iminodiacetic Acid (HIDA) Scan (Cholescintigraphy): This nuclear medicine scan is highly sensitive and specific for acute cholecystitis. It involves injecting a radioactive tracer that is taken up by hepatocytes and excreted into the bile. Non-visualization of the gallbladder indicates cystic duct obstruction.

Magnetic Resonance Cholangiopancreatography (MRCP): A non-invasive MRI technique that provides detailed images of the biliary and pancreatic ducts, useful for detecting common bile duct stones (choledocholithiasis) or other ductal pathologies.

Endoscopic Ultrasound (EUS) / Endoscopic Retrograde Cholangiopancreatography (ERCP): These are more invasive procedures. EUS can detect small stones in the bile ducts. ERCP is therapeutic as well as diagnostic; it can remove stones from the common bile duct but carries risks.

Complications of Acute Cholecystitis

Empyema or Abscess: Formation of pus within the gallbladder, leading to severe localized infection. This is a life-threatening complication.
Perforation: Rupture of the inflamed and necrotic gallbladder wall, leading to leakage of bile into the peritoneal cavity, causing biliary peritonitis (a severe and generalized infection of the abdominal cavity). This often requires emergency surgery.
Fistula Formation: An abnormal connection between the gallbladder and an adjacent organ (e.g., duodenum, colon), known as a cholecystoenteric fistula. This can lead to gallstone ileus if a large stone passes into the bowel and obstructs it.
Gangrene of the gallbladder: This occurs due to severe inflammation and compromised blood supply, leading to tissue death. It significantly increases the risk of perforation.
Gallstone Ileus: Mechanical bowel obstruction caused by a large gallstone that has passed into the intestinal lumen, usually through a cholecystoenteric fistula.
Choledocholithiasis: The presence of gallstones in the common bile duct, which can lead to cholangitis (infection of the bile ducts) or pancreatitis.
Cholangitis: An acute inflammation and infection of the bile ducts, usually due to obstruction by stones and bacterial ascent from the duodenum. It is a severe, life-threatening condition.
Pancreatitis: Inflammation of the pancreas, often caused by a gallstone obstructing the common bile duct at the ampulla of Vater, causing reflux of bile into the pancreatic duct.

Management of Cholecystitis

Management of acute cholecystitis typically involves a combination of conservative (medical) and surgical approaches, tailored to the patient's severity (as per the Tokyo Guidelines classification), co-morbidities, and clinical response.

Conservative Management (Medical)

This approach is often used initially to stabilize the patient, particularly in mild to moderate cases, or as a bridge to definitive surgical treatment.

Aims of Medical Management

To treat and prevent the underlying cause of inflammation, primarily bacterial infection.
To relieve symptoms, especially severe pain, nausea, and vomiting.
To prevent further complications, such as gallbladder perforation, gangrene, or systemic sepsis.
To optimize the patient's condition for eventual surgical intervention, if indicated.

Interventions

Nil Per Mouth (NPO/NBM - Nil by Mouth): The patient is kept NPO to rest the gastrointestinal tract and, crucially, to minimize stimulation of the gallbladder, reducing pain and inflammation. This prevents further contraction of the gallbladder and bile flow.
Intravenous (IV) Fluids: Essential to maintain adequate hydration, correct any electrolyte imbalances (especially if the patient has been vomiting), and provide a route for medication administration.
Pain Management: Analgesics are given to control severe pain. Opioids like Pethidine (meperidine) or morphine are commonly used. Non-steroidal anti-inflammatory drugs (NSAIDs) may also be used in conjunction or for milder pain, provided there are no contraindications (e.g., renal impairment, bleeding risk).
- Note: Historically, morphine was thought to cause spasm of the sphincter of Oddi, but current evidence suggests its clinical significance in this context is minimal, and it is a safe and effective analgesic for biliary pain.
Antibiotics: IV antibiotics are administered promptly to treat and prevent bacterial infection, as bacterial invasion of the inflamed gallbladder wall is common. Broad-spectrum antibiotics covering common enteric organisms (e.g., E. coli, Klebsiella, Enterococcus) are typically initiated, such as third-generation cephalosporins (e.g., Ceftriaxone), fluoroquinolones (e.g., Ciprofloxacin), or combinations like Piperacillin-Tazobactam. The choice may be refined based on culture results if obtained (e.g., from bile).
Antiemetics: Medications such as Ondansetron, Metoclopramide, or Prochlorperazine are administered to control nausea and vomiting, improving patient comfort and reducing the risk of dehydration.
Nasogastric (NG) Tube: May be inserted if the patient has severe vomiting or gastric distension to decompress the stomach.

Surgical Management

Cholecystectomy (surgical removal of the gallbladder) is the definitive treatment for acute cholecystitis and is the standard of care for most patients. It eliminates the source of inflammation and prevents recurrence. The timing of surgery depends on the severity of the cholecystitis, the patient's overall condition, and the surgeon's preference.

Laparoscopic Cholecystectomy: This is the most common and preferred surgical approach. It is a minimally invasive procedure performed through small incisions, offering benefits such as less pain, shorter hospital stay, and faster recovery. It is typically performed:
- Early (within 24-72 hours of symptom onset): This is increasingly favored, especially for mild to moderate cases, as it can reduce hospital stay and complications associated with prolonged inflammation.
- Delayed (after resolution of acute inflammation): For patients who are initially managed conservatively due to severe inflammation, co-morbidities, or delayed presentation. The patient is discharged and readmitted for elective surgery usually 6-8 weeks later, once the inflammation has subsided ("interval cholecystectomy").
Open Cholecystectomy: This involves a larger incision in the abdomen and is reserved for cases where laparoscopic surgery is contraindicated or technically challenging (e.g., severe inflammation, adhesion, morbid obesity, suspicion of malignancy, or if complications arise during laparoscopic surgery).
Percutaneous Cholecystostomy: In critically ill patients who are not surgical candidates due to high operative risk, a percutaneous cholecystostomy tube may be inserted under imaging guidance to drain the gallbladder and relieve pressure and inflammation. This is often a temporizing measure to stabilize the patient, with cholecystectomy performed later when the patient's condition improves.

Nursing Diagnoses and Interventions for Cholecystitis

Below are common nursing diagnoses for patients with cholecystitis, along with their associated nursing interventions.

1. Acute Pain

Related to: Inflammation and distension of the gallbladder, muscle spasm, biliary colic, surgical incision (post-op).

Evidenced by: Patient report of pain (e.g., RUQ pain radiating to shoulder/back), guarding behavior, facial grimacing, restlessness, changes in vital signs (tachycardia, hypertension).

Nursing Interventions:

Assess Pain: Use a standardized pain scale (0-10) to assess pain intensity, location, character, and aggravating/alleviating factors regularly.
Administer Analgesics: Administer prescribed analgesics (opioids, NSAIDs) promptly and evaluate their effectiveness. Consider multimodal pain management.
Positioning: Assist the patient to a comfortable position, often semi-Fowler's, to reduce pressure on the abdomen.
Rest: Encourage bed rest during acute pain episodes to reduce metabolic demand and discomfort.
NPO Status: Maintain NPO status as ordered to minimize gallbladder stimulation.
Relaxation Techniques: Teach and encourage deep breathing, guided imagery, or distraction techniques.
Post-operative Pain Management: Provide continuous assessment of incisional pain, administer analgesics (oral, IV, PCA), and encourage splinting the incision during coughing/movement.

2. Nausea and Vomiting

Related to: Inflammation, pain, biliary stasis, irritation of gastric mucosa, side effects of medications.

Evidenced by: Patient reports of nausea, observed vomiting, retching, aversion to food, signs of dehydration.

Nursing Interventions:

Assess Nausea/Vomiting: Monitor frequency, amount, and character of emesis. Assess for associated symptoms (e.g., abdominal pain, dizziness).
Administer Antiemetics: Give prescribed antiemetics (e.g., Ondansetron, Metoclopramide) promptly and evaluate effectiveness.
Maintain NPO Status: Adhere to NPO orders. Progress diet slowly after symptoms subside, starting with clear liquids.
Oral Hygiene: Provide frequent mouth care, especially after vomiting, to remove unpleasant tastes and odors.
Environmental Control: Minimize unpleasant odors, provide a well-ventilated and quiet environment.
IV Fluids: Ensure adequate IV fluid replacement to prevent dehydration and electrolyte imbalances.
NG Tube Management: If an NG tube is in place, ensure it is patent and draining effectively.

3. Deficient Fluid Volume / Risk for Deficient Fluid Volume

Related to: Nausea, vomiting, NPO status, fever, inflammation.

Evidenced by: Dry mucous membranes, decreased skin turgor, decreased urine output, concentrated urine, hypotension, tachycardia, weight loss, electrolyte imbalances.

Nursing Interventions:

Monitor Fluid Balance: Accurately record strict intake and output. Monitor daily weight.
Assess Hydration Status: Check skin turgor, mucous membranes, thirst, and capillary refill.
Monitor Vital Signs: Assess for signs of hypovolemia (tachycardia, hypotension).
Administer IV Fluids: Administer prescribed IV fluids as ordered to maintain hydration and correct electrolyte imbalances.
Monitor Electrolytes: Review laboratory results for electrolyte abnormalities (e.g., sodium, potassium, chloride).
Oral Rehydration: Once tolerated, encourage sips of clear fluids and gradually advance diet.
Educate Patient/Family: On the importance of hydration and reporting symptoms of dehydration.

4. Risk for Infection (or Imbalanced Body Temperature: Hyperthermia)

Related to: Inflammation of the gallbladder, potential for bacterial invasion, surgical wound (post-op).

Evidenced by: (Potential for) Elevated temperature, chills, elevated WBC count, localized tenderness, purulent drainage (post-op).

Nursing Interventions:

Monitor for Signs of Infection: Monitor temperature regularly (e.g., every 4 hours), assess for chills, increased pain, or localized tenderness. Review WBC count.
Administer Antibiotics: Administer prescribed IV antibiotics promptly and ensure the full course is completed. Monitor for effectiveness and side effects.
Aseptic Technique: Maintain strict aseptic technique for all invasive procedures (IV insertion, wound care post-op).
Wound Care (Post-op): Assess surgical incision for redness, swelling, heat, pain, and drainage. Perform wound dressing changes as ordered using sterile technique.
Pulmonary Hygiene (Post-op): Encourage deep breathing, coughing, and incentive spirometry to prevent atelectasis and pneumonia.
Hydration and Nutrition: Promote adequate hydration and nutrition to support the immune system.
Patient Education: Educate on signs of infection to report, proper hand hygiene, and wound care (if applicable).

5. Knowledge Deficit

Related to: Lack of exposure to information regarding cholecystitis, diagnostic procedures, treatment, and self-care.

Evidenced by: Patient or family asking questions, expressing misconceptions, non-adherence to treatment plan, inappropriate behaviors.

Nursing Interventions:

Assess Knowledge Level: Determine the patient's and family's current understanding of cholecystitis, its causes, treatment options, and post-discharge care.
Provide Information: Explain the diagnosis, planned investigations, medical management, and surgical options in clear, understandable language. Use visual aids if helpful.
Pre-operative Teaching: If surgery is planned, educate on the procedure, expected post-operative course, pain management, early ambulation, and wound care.
Dietary Education: Explain the importance of a low-fat diet post-discharge to minimize discomfort and prevent recurrence, especially after cholecystectomy.
Medication Education: Discuss all prescribed medications (purpose, dose, frequency, side effects, storage).
Symptom Management: Educate on how to manage pain, nausea, and other symptoms at home.
Warning Signs: Instruct on when to seek immediate medical attention (e.g., worsening pain, fever, jaundice, persistent vomiting).
Follow-up Care: Emphasize the importance of attending follow-up appointments.
Encourage Questions: Create an open environment for questions and clarification. Provide written materials for reinforcement.

CHOLECYSTITIS Lecture Notes Read More »

Liver Cirrhosis

Nursing Notes - Biliary System and Liver

LIVER CIRRHOSIS

Cirrhosis is a chronic, irreversible disease characterized by the replacement of normal liver tissue with diffuse fibrosis (scar tissue). This scarring disrupts the normal structure and function of the liver, leading to necrosis of liver cells, nodule formation, and distortion of the liver's vascular network.

Types of Liver Cirrhosis

Alcoholic Cirrhosis (Laennec's Cirrhosis): The most common type, resulting from chronic alcohol ingestion and associated malnutrition. The scar tissue characteristically surrounds the portal areas.
Post-necrotic Cirrhosis: Characterized by broad bands of scar tissue, this type is often a late result of a previous acute viral hepatitis infection (especially Hepatitis B and C).
Biliary Cirrhosis: Scarring occurs around the bile ducts due to chronic biliary obstruction and infection (cholangitis). It is much less common.
Cardiac Cirrhosis: Results from long-standing, severe, right-sided heart failure, which causes chronic congestion and damage to the liver.

Causes of Liver Cirrhosis

Infections: Chronic viral hepatitis B and C are major causes.
Intoxication: Chronic, excessive alcohol consumption is the leading cause. Other toxins and drugs (e.g., methotrexate, isoniazid) can also cause cirrhosis.
Metabolic and Infiltrative Disorders: Non-alcoholic fatty liver disease (NAFLD), Wilson's disease (copper overload), and hemochromatosis (iron overload).
Biliary Obstruction: Chronic congestion with bile (e.g., primary biliary cirrhosis - PBC).
Vascular Congestion: Chronic congestion with blood (e.g., Budd-Chiari syndrome, cardiac failure).
Idiopathic: In some cases, the cause is unknown.

Clinical Features of Liver Cirrhosis

Signs and symptoms increase in severity as the disease progresses. Cirrhosis is often categorized as compensated or decompensated.

Compensated Cirrhosis

In this early stage, the liver is still able to perform most of its functions. Symptoms are often vague and may be discovered incidentally.

Intermittent mild fever.
Vascular spiders (spider angiomas) on the skin.
Palmar erythema (reddened palms).
Unexplained epistaxis (nosebleeds).
Ankle edema.
Vague morning indigestion and flatulent dyspepsia.
Abdominal pain.
A firm, enlarged liver (hepatomegaly) and splenomegaly.

Decompensated Cirrhosis

This is the late stage, where the liver is failing and signs of portal hypertension and liver insufficiency are prominent.

Ascites: Accumulation of fluid in the peritoneal cavity.
Jaundice: Yellowing of the skin and eyes.
Weakness and Muscle Wasting.
Weight Loss.
Endocrine Changes:
- Loss of libido, testicular atrophy, gynecomastia (in males).
- Amenorrhea, irregular menses, breast atrophy (in females).
Bleeding Tendencies: Spontaneous bruising, purpura (due to low platelet count), and epistaxis.
Hepatic Encephalopathy: Confusion, altered mental state, and asterixis ("liver flap") due to the accumulation of ammonia.
Other signs: Hair loss, finger clubbing, edema of the legs, and pain in the right upper abdominal quadrant.

Investigations for Liver Cirrhosis

Liver Function Tests (LFTs): To assess liver functional abnormalities. Shows elevated liver enzymes (AST, ALT), alkaline phosphatase, and bilirubin. Serum albumin will be low.
Complete Blood Count (CBC): To detect anemia and thrombocytopenia (low platelet count).
Serological Tests: Blood tests to rule out viral hepatitis (B, C) and HIV.
Coagulation Studies: Prothrombin Time (PT) will be prolonged due to decreased synthesis of clotting factors.
Serum Electrolytes: To check for imbalances, especially hyponatremia.
Abdominal Ultrasound: To reveal the size of the liver (can be enlarged or shrunken), assess for nodules, ascites, and other hepatic abnormalities.
CT Scan: To assess for lobe enlargement, vascular changes, and nodules in more detail.
Endoscopy (EGD): Crucial for identifying and assessing esophageal varices, a major complication of portal hypertension.
Liver Biopsy: The definitive test to confirm the diagnosis by revealing the destruction and fibrosis of liver tissues.

Management of a Patient with Liver Cirrhosis

Liver cirrhosis is a late-stage liver disease where healthy liver tissue is replaced by scar tissue, leading to irreversible liver damage and impaired liver function. Management is complex and aims to prevent further progression, manage complications, and improve the patient's quality of life.

Aims of Management

To remove or alleviate the underlying cause of cirrhosis (e.g., abstinence from alcohol for alcoholic liver disease, antiviral therapy for chronic viral hepatitis).
To prevent further liver damage and, where possible, promote regeneration of remaining healthy liver tissue.
To prevent and effectively treat complications arising from portal hypertension and liver dysfunction (e.g., ascites, variceal bleeding, hepatic encephalopathy, spontaneous bacterial peritonitis).
To improve the patient's quality of life and functional status.

Nursing Care Plan for Patients with Liver Cirrhosis

Nursing care is pivotal in managing symptoms, preventing complications, educating patients and families, and providing comprehensive supportive care.

1. Admission and Initial Assessment

Placement: Admit the patient to a medical ward. Ensure a quiet, calm, well-ventilated environment conducive to rest.

Information Gathering: Obtain comprehensive patient particulars and medical history from the patient or their relatives. This quick history is crucial for establishing the likely cause of cirrhosis and guiding immediate medical management. Document all findings in the admission records.

Physician Notification: Immediately inform the attending physician of the patient's admission and preliminary findings to facilitate prompt medical assessment and orders.

Psychological Care:

Establish Therapeutic Rapport: Build trust and rapport with the patient and family.
Provide Counseling and Reassurance: Explain the condition, the management plan, and the importance of adherence to treatment in clear, understandable terms. Address anxieties and fears openly and empathetically. Encourage questions.

2. Ongoing Monitoring and Observations

Positioning: Nurse the patient in a position of comfort that optimizes breathing and circulation. For patients with ascites and dyspnea, a semi-Fowler's or high-Fowler's position is often preferred to alleviate pressure on the diaphragm and improve lung expansion.

Vital Observations:

Monitor temperature, pulse, respiration, blood pressure, and oxygen saturation regularly (e.g., hourly, 2-hourly, or as ordered based on the patient's condition).
Maintain an accurate observation chart.
Report any abnormalities immediately (e.g., hypotension, tachycardia, fever, tachypnea), as these could indicate complications like bleeding, infection, or worsening liver failure.

Specific/Physical Observations: Continuously monitor for and document:

Skin: Jaundice (assess sclera, skin), severe pruritus, and skin integrity (assess for excoriations, pressure areas, edema, spider angiomas, palmar erythema).
Bleeding: Signs of internal or external bleeding (epistaxis, hematemesis, melena, hematochezia, petechiae, purpura, easy bruising, bleeding gums).
Neurological Status: Assess for signs of hepatic encephalopathy – confusion, disorientation, lethargy, slurred speech, asterixis (flapping tremors), changes in sleep-wake cycle, and ultimately coma. Use a grading scale (e.g., West Haven Criteria) if appropriate.
Abdominal Assessment: Abdominal girth measurements (daily, at the same level) and assessment for fluid wave to quantify ascites. Note any tenderness or guarding.
Edema: Peripheral edema (pitting vs. non-pitting, location, severity).
Gastrointestinal: Nausea, vomiting, indigestion, abdominal discomfort, changes in bowel habits.
Symptom Intensity: Note the intensity of all symptoms and report significant changes to the medical team.

3. Diagnostic Investigations

Prepare the patient and assist with various investigations as ordered to confirm diagnosis, assess liver function, identify etiology, and monitor for complications:

Complete Blood Count (CBC): To check for anemia (due to chronic bleeding, malnutrition, or hemolysis), leukopenia, and thrombocytopenia (due to hypersplenism).
Liver Function Tests (LFTs): Bilirubin (total and direct), AST, ALT, ALP, GGT to monitor liver synthetic and excretory function.
Coagulation Profile: Prothrombin Time (PT), International Normalized Ratio (INR), Partial Thromboplastin Time (PTT) to assess clotting ability (impaired in liver dysfunction).
Kidney Function Tests: Urea, Creatinine, Electrolytes to monitor renal function, especially with diuretics or potential hepatorenal syndrome.
Serum Albumin: To assess liver synthetic function and risk of ascites/edema.
Serum Ammonia: To monitor for hepatic encephalopathy.
Serology: Blood tests for Hepatitis B (HBsAg, anti-HBc, HBeAg), Hepatitis C (anti-HCV, HCV RNA), Hepatitis D, and HIV to identify viral causes. Autoimmune markers if suspected.
Imaging Studies:
- Abdominal Ultrasound: To assess liver size, texture, presence of ascites, portal vein patency, and rule out hepatocellular carcinoma.
- CT Scan/MRI: Provides more detailed imaging of the liver and associated structures.
Liver Biopsy: The gold standard for confirming the diagnosis of cirrhosis, assessing its severity, and sometimes identifying the specific etiology (though often not required if clinical and imaging evidence is conclusive).
Esophagogastroduodenoscopy (EGD): To screen for and manage esophageal varices.

4. Pharmacological Management

Administer all prescribed medications accurately and on time. Maintain an accurate treatment chart. Common medications include:

Diuretics: For ascites and edema. Spironolactone (a potassium-sparing diuretic) is often the first-line and is frequently combined with Furosemide (a loop diuretic) for synergistic effects. Monitor fluid balance and electrolytes carefully.
Antiviral Treatment: For chronic Hepatitis B or C to manage the underlying cause and prevent disease progression.
Lactulose: To reduce ammonia levels in patients with hepatic encephalopathy. It works as a laxative, promoting ammonia excretion in stool, and acidifies the colon, trapping ammonia.
Rifaximin: A non-absorbable antibiotic sometimes used in conjunction with lactulose to reduce ammonia-producing bacteria in the gut.
Vitamin Supplements:
- Vitamin B complex (especially thiamine, folate, B12) for nutritional deficiencies and to prevent Wernicke-Korsakoff syndrome in alcoholic cirrhosis.
- Vitamin K: May be given to correct clotting abnormalities due to impaired synthesis of clotting factors.
- Fat-soluble vitamins (A, D, E) if cholestasis is significant.
Beta-blockers (e.g., Propranolol, Carvedilol): To reduce portal pressure and prevent variceal bleeding.
Proton Pump Inhibitors (PPIs) or H2 Blockers: To decrease gastric acid secretion and prevent stress ulcers.
Antibiotics: For infections (e.g., IV Ceftriaxone for spontaneous bacterial peritonitis).
Albumin: Intravenous albumin infusions may be given during large-volume paracentesis or for severe hypoalbuminemia.
Analgesics: Administer pain relief as prescribed (e.g., Tramadol). Avoid hepatotoxic drugs, especially NSAIDs and high doses of paracetamol, which can exacerbate liver damage or increase bleeding risk.
Antiemetics: (e.g., Metoclopramide) for nausea and vomiting.

5. Non-Pharmacological Management & Lifestyle Modifications

Abstinence from Alcohol: Complete and lifelong avoidance of alcohol is the single most crucial intervention for alcoholic cirrhosis to halt disease progression and allow for potential liver recovery.

Appropriate Nutrition:

Provide a well-balanced diet adequate in calories and protein to promote liver regeneration and prevent malnutrition.
Protein Moderation/Restriction: While protein is essential, it must be restricted only if the patient shows signs of hepatic encephalopathy (as protein breakdown produces ammonia). Otherwise, adequate protein intake is encouraged.
Sodium Restriction: A strict low-sodium diet (< 2g/day) is essential to help manage and prevent ascites and peripheral edema.

Fluid Restriction: Usually only required if dilutional hyponatremia is present and severe.

Bed Rest and Moderate Exercise: During acute decompensation, bed rest reduces metabolic demands on the liver. As the patient improves, encourage and support active exercises to prevent deconditioning, respiratory complications, and deep vein thrombosis (DVT).

Avoidance of Hepatotoxic Agents: Educate the patient to avoid all known hepatotoxins, including certain over-the-counter medications (e.g., acetaminophen in high doses), herbal remedies, and illicit drugs, without consulting their physician.

6. Surgical Treatment and Procedures

Paracentesis: A therapeutic procedure to remove excess ascitic fluid from the peritoneal cavity for symptom relief (dyspnea, abdominal discomfort). Often followed by infusions of salt-poor albumin, particularly after large volume paracentesis (>5L), to prevent post-paracentesis circulatory dysfunction.

Endoscopic Sclerotherapy or Band Ligation: Procedures performed via endoscopy to treat acute bleeding from esophageal varices or to prevent re-bleeding by obliterating the varices.

Transjugular Intrahepatic Portosystemic Shunt (TIPS): A radiological procedure that creates a shunt within the liver to relieve portal hypertension by diverting blood flow from the portal vein directly into the hepatic vein. Used for refractory ascites or recurrent variceal bleeding not controlled by endoscopic means.

Liver Transplantation: The definitive treatment for patients with advanced, end-stage liver disease who meet specific criteria. It offers the potential for long-term survival and improved quality of life.

7. Elimination Management

Bladder Care: Offer a bedpan or urinal regularly. Monitor urine output meticulously for color and amount. Maintain an accurate fluid balance chart (strict intake and output) to assess hydration status and response to diuretics.

Bowel Care: Offer a bedpan or commode. Observe stool for color (checking for melena or hematochezia) and consistency. Administer medications like lactulose as prescribed to treat constipation and reduce ammonia levels by promoting regular bowel movements.

8. Hygiene and Skin Care

Daily Hygiene: Provide daily bed baths or assist with showers to ensure comfort and cleanliness.

Meticulous Skin Care: Patients with cirrhosis are highly prone to skin breakdown due to edema, pruritus, malnutrition, and impaired clotting.

Inspect skin daily for signs of breakdown, excoriations, or infection.
Use mild soaps and moisturizers.
Implement 4-hourly repositioning and use pressure-relieving devices (e.g., special mattresses, cushions) to prevent pressure sores.
Manage pruritus effectively (see symptom management above).

Oral Care: Perform daily oral care to prevent oral complications (e.g., gum bleeding) and stimulate appetite.

9. Activity and Mobility

Physiotherapy/Exercises: Provide passive range of motion exercises for patients on bed rest to prevent joint stiffness and muscle atrophy. As the patient's condition improves, encourage and support active exercises, deep breathing exercises, and progressive ambulation to prevent respiratory complications (e.g., hypostatic pneumonia) and circulatory complications (e.g., DVT).

Rest and Sleep: Ensure a quiet and restful environment by minimizing noise, dimming lights, and restricting non-essential visitors. Administer medications in a timely manner to manage symptoms (like pain, pruritus, or insomnia) that may interfere with sleep.

10. Discharge Planning and Education

When the patient's condition has stabilized and they are deemed fit for discharge, provide comprehensive education to the patient and their family to ensure continuity of care and prevent readmission:

Medication Adherence: Emphasize the importance of taking all prescribed medications exactly as ordered, understanding their purpose, and completing the full course. Educate on potential side effects.

Rest and Activity: Advise on the need for adequate rest at home to conserve energy and promote recovery, balanced with gentle, regular exercise as tolerated.

Dietary Guidelines: Reinforce adherence to a well-balanced, low-sodium diet. Reiterate the absolute avoidance of alcohol. Discuss protein intake guidelines based on whether hepatic encephalopathy is a concern.

Monitoring for Complications: Educate on signs and symptoms of worsening cirrhosis or complications (e.g., increased abdominal swelling, confusion, new bleeding, fever, worsening jaundice) and when to seek immediate medical attention.

Follow-up Appointments: Emphasize the importance of attending all scheduled follow-up appointments with physicians and other healthcare providers.

Medication Storage: Advise on proper storage of medications (dry, cool place, out of reach of children).

Lifestyle Adjustments: Discuss avoidance of illicit drugs, certain over-the-counter medications, and supplements without medical advice.

Complications of Liver Cirrhosis

The major complications of liver cirrhosis primarily stem from two pathological processes: portal hypertension and progressive liver cell failure. These complications are often life-threatening and require prompt and aggressive management.

Portal Hypertension: This is a key complication resulting from increased resistance to blood flow through the cirrhotic liver. The scar tissue obstructs the normal flow of blood from the portal vein (which collects blood from the GI tract and spleen) into the hepatic veins. This leads to an increase in blood pressure within the portal venous system, which then causes a cascade of other complications.
Variceal Hemorrhage: Due to portal hypertension, blood is shunted into collateral vessels, particularly in the esophagus and stomach (esophageal and gastric varices). These vessels are thin-walled, fragile, and not designed for high pressure. They are prone to rupture, leading to life-threatening gastrointestinal bleeding. Bleeding can be triggered by muscular exertion (e.g., straining during defecation, severe coughing), irritation from food, or gastric reflux. This is a medical emergency.
Ascites: The accumulation of large amounts of fluid in the peritoneal (abdominal) cavity. It is caused by a combination of high pressure in the portal system (forcing fluid out of vessels), low levels of serum albumin (due to impaired liver synthesis, reducing oncotic pressure and leading to fluid leakage from vessels), and renal retention of sodium and water.
Hepatic Encephalopathy: A complex, reversible neuropsychiatric syndrome resulting from the accumulation of toxic substances in the blood, primarily ammonia, which the damaged liver can no longer effectively detoxify. These toxins bypass the liver via shunts and reach the brain, leading to altered mental status, confusion, disorientation, changes in personality, asterixis (flapping tremors), and can progress to stupor and coma. Precipitating factors include GI bleeding, infection, constipation, high protein intake, and electrolyte imbalances.
Spontaneous Bacterial Peritonitis (SBP): A severe infection of the ascitic fluid that occurs in the absence of an obvious source of infection. It is a common and life-threatening complication in patients with ascites, believed to occur due to bacterial translocation from the gut into the ascitic fluid. Signs include fever, abdominal pain, and worsening encephalopathy.
Hepatorenal Syndrome (HRS): A severe and often fatal complication characterized by progressive kidney failure in people with advanced liver disease, particularly cirrhosis. It is a functional renal failure, meaning there is no intrinsic kidney disease; rather, it results from severe vasoconstriction of renal arteries due to complex circulatory abnormalities in liver failure, leading to reduced blood flow to the kidneys.
Hepatopulmonary Syndrome (HPS): A triad of liver disease, intrapulmonary vascular dilations, and arterial hypoxemia. It results from abnormal vasodilation of the pulmonary capillaries, leading to impaired gas exchange.
Portopulmonary Hypertension: Pulmonary hypertension that develops in patients with portal hypertension, not directly related to HPS, but due to pulmonary arterial vasoconstriction.
Hepatocellular Carcinoma (HCC): Cirrhosis, regardless of its cause, is the strongest risk factor for the development of primary liver cancer. Regular screening for HCC is crucial.
Coagulopathy: Impaired synthesis of clotting factors by the diseased liver leads to increased bleeding tendencies.
Malnutrition and Muscle Wasting: Common due to anorexia, malabsorption, and altered metabolism.
Infections: Patients with cirrhosis are immunocompromised and highly susceptible to various infections (e.g., pneumonia, UTIs, skin infections, SBP).

Nursing Diagnoses and Interventions for Liver Cirrhosis

Below are common nursing diagnoses for patients with liver cirrhosis, along with their associated nursing interventions.

1. Excess Fluid Volume

Related to: Impaired regulatory mechanisms (e.g., renal sodium and water retention), portal hypertension, decreased plasma albumin.

Evidenced by: Edema (peripheral, sacral), ascites, weight gain, dyspnea, increased abdominal girth, altered electrolyte levels.

Nursing Interventions:

Monitor Fluid Balance: Accurately measure and record daily weight, strict intake and output.
Assess Edema and Ascites: Measure abdominal girth daily at the same level. Assess for peripheral and sacral edema (pitting vs. non-pitting).
Administer Diuretics: Give prescribed diuretics (e.g., Spironolactone, Furosemide) and monitor their effectiveness.
Monitor Electrolytes: Closely monitor serum sodium, potassium, and creatinine levels, reporting abnormalities.
Restrict Sodium: Implement and educate patient/family on a strict low-sodium diet as ordered.
Fluid Restriction: Implement fluid restriction only if ordered and necessary (e.g., severe dilutional hyponatremia).
Positioning: Elevate edematous extremities. Elevate the head of the bed (semi-Fowler's) to improve breathing if ascites is causing dyspnea.
Skin Care: Provide meticulous skin care to edematous areas to prevent breakdown.
Patient Education: Educate on rationale for sodium/fluid restriction, medication regimen, and reporting increased swelling or weight gain.

2. Inadquate protein energy intake

Related to: Anorexia, nausea, impaired metabolism and absorption, altered fat and protein digestion/absorption (due to reduced bile production or portal hypertension affecting gut).

Evidenced by: Weight loss, muscle wasting, decreased albumin, electrolyte imbalances, fatigue.

Nursing Interventions:

Assess Nutritional Status: Monitor weight, evaluate dietary intake, assess for signs of malnutrition (muscle wasting, skin turgor).
Provide Nutritional Support: Collaborate with a dietitian to develop an individualized meal plan.
Offer Small, Frequent Meals: To improve tolerance and increase overall intake.
Encourage Calorie-Dense Foods: Unless contraindicated.
Protein Management: Provide adequate protein unless signs of hepatic encephalopathy are present. If encephalopathy, moderate protein intake as directed.
Administer Vitamin Supplements: As prescribed (e.g., B vitamins, fat-soluble vitamins, Vitamin K).
Manage Nausea: Administer antiemetics before meals as prescribed.
Oral Hygiene: Provide meticulous oral care before meals to enhance appetite.
Create Pleasant Environment: Ensure a comfortable and appealing environment for meals.
Patient Education: Educate on dietary modifications, avoidance of alcohol, and importance of nutrition.

3. Risk for Bleeding

Related to: Impaired liver synthesis of clotting factors, portal hypertension leading to esophageal/gastric varices, thrombocytopenia (hypersplenism).

Evidenced by: (Potential for) Hematemesis, melena, epistaxis, petechiae, purpura, easy bruising, prolonged PT/INR.

Nursing Interventions:

Monitor for Bleeding: Routinely assess for signs of bleeding (check stool for melena, emesis for coffee grounds/bright blood, urine for hematuria, skin for petechiae/ecchymosis).
Monitor Coagulation Profile: Review PT/INR, PTT, and platelet count.
Administer Vitamin K: As prescribed to improve clotting factor synthesis.
Avoid Trauma: Use soft toothbrushes, electric razors. Avoid IM injections if possible; if given, use smallest gauge needle and apply prolonged pressure.
Prevent Constipation/Straining: Encourage high-fiber diet, fluids, and administer stool softeners/laxatives (like lactulose) to prevent straining, which can increase variceal pressure.
Administer Medications to Reduce Portal Pressure: Beta-blockers as prescribed.
Prepare for Endoscopic Procedures: If varices are known, prepare patient for EGD and band ligation/sclerotherapy.
Emergency Preparedness: Have emergency equipment (e.g., Sengstaken-Blakemore tube, IV access) readily available if variceal hemorrhage is suspected.
Patient Education: Educate on bleeding precautions, signs of bleeding to report, and medication adherence.

4. Altered Thought Processes / Risk for Acute Confusion

Related to: Accumulation of toxins (especially ammonia) due to impaired liver detoxification.

Evidenced by: Changes in LOC (lethargy, disorientation), confusion, asterixis, personality changes, slurred speech, impaired judgment.

Nursing Interventions:

Assess Neurological Status: Perform frequent neurological assessments, including LOC, orientation, presence of asterixis, and appropriateness of behavior/speech. Use a standardized scale if applicable.
Monitor Ammonia Levels: Review serum ammonia levels.
Administer Medications: Give lactulose as prescribed to reduce ammonia (monitor for desired number of soft stools per day). Administer rifaximin if ordered.
Protein Restriction: If severe encephalopathy, ensure adherence to prescribed protein restriction (usually temporary).
Ensure Bowel Regularity: Encourage regular bowel movements to excrete ammonia.
Safety Precautions: Implement fall precautions (side rails up, bed in low position, assist with ambulation). Supervise activities.
Maintain Calm Environment: Minimize sensory overload. Provide reorientation as needed (calendar, clock).
Communicate Clearly: Use simple, direct commands. Allow time for response.
Family Education: Educate family on signs of encephalopathy and rationale for treatment.

5. Impaired Skin Integrity / Risk for Impaired Skin Integrity

Related to: Edema, pruritus (scratching), malnutrition, altered clotting factors, jaundice.

Evidenced by: Excoriations, dryness, bruising, pressure ulcers.

Nursing Interventions:

Assess Skin Daily: Inspect skin for signs of breakdown, dryness, excoriations, color changes, and bruising.
Pressure Area Care: Turn patient every 2 hours or use pressure-relieving devices (e.g., air mattress, foam cushions).
Moisturize Skin: Apply emollients and lotions to dry skin.
Manage Pruritus: Administer anti-itch medications (e.g., cholestyramine, antihistamines) as prescribed. Keep nails short, suggest wearing soft cotton clothing. Provide cool baths.
Gentle Skin Care: Use mild soaps and avoid harsh scrubbing. Pat skin dry gently.
Nutrition: Promote good nutrition to support skin healing and integrity.
Protect from Injury: Pad side rails if patient is agitated or confused.

6. Risk for Infection

Related to: Immunosuppression (impaired Kupffer cell function), ascites (risk of SBP), invasive procedures (paracentesis, endoscopy).

Evidenced by: (Potential for) Fever, chills, increased WBC, signs of peritonitis, worsening encephalopathy.

Nursing Interventions:

Monitor for Signs of Infection: Monitor temperature, WBC count. Assess for new onset or worsening abdominal pain, fever, or changes in mental status (suggesting SBP).
Aseptic Technique: Use strict aseptic technique for all invasive procedures (IV insertion, paracentesis, Foley catheterization).
Promote Pulmonary Hygiene: Encourage deep breathing and coughing to prevent pneumonia.
Administer Antibiotics: As prescribed for diagnosed infections (e.g., SBP prophylaxis or treatment).
Good Hand Hygiene: Educate patient, family, and staff on proper hand hygiene.
Avoid Crowds: Advise patient to avoid large crowds and sick individuals.
Vaccinations: Educate on importance of influenza and pneumococcal vaccines.

7. Activity Intolerance

Related to: Fatigue, generalized weakness, muscle wasting, dyspnea (due to ascites), malnutrition, anemia.

Evidenced by: Reports of fatigue, weakness, dyspnea on exertion, inability to perform ADLs.

Nursing Interventions:

Assess Activity Level: Determine current activity tolerance and level of fatigue.
Promote Rest: Provide undisturbed periods of rest. Organize care to allow for rest.
Gradual Increase in Activity: Encourage progressive activity as tolerated. Collaborate with physical therapy for mobility plan.
Assist with ADLs: Provide assistance with self-care activities as needed to conserve energy.
Positioning: Elevate head of bed to ease breathing during activity.
Nutrition: Promote optimal nutrition to improve energy levels.
Patient Education: Educate on energy conservation techniques and importance of balancing rest and activity.

Liver Cirrhosis Read More »

JAUNDICE (Hyperbilirubinemia)

Nursing Notes - Biliary System and Liver

Disorders of the Biliary System

Review of Liver Disorders

Liver disorders are common and can result from various causes, including viral infections (hepatitis) or exposure to toxic substances like alcohol. A significant and often fatal liver disorder is hepatocellular carcinoma, a highly malignant tumor that is difficult to treat. While it accounts for less than 1% of cancers in the United States, it is a major health issue elsewhere, accounting for up to 50% of cancer cases in some parts of the world. Liver cancer can originate in the liver (primary) or metastasize to the liver from other sites.

Anatomy and Physiology of the Liver

The liver is the largest gland in the body, weighing about 1,500 g (1.5 kg). It functions as a complex "chemical factory" that manufactures, stores, metabolizes, and excretes a vast number of substances essential for life.

Location and Structure

The liver is located in the upper right portion of the abdominal cavity, situated behind the ribs.
It is divided into four lobes. A thin layer of connective tissue surrounds each lobe and extends into it, dividing the liver mass into microscopic functional units called lobules.

Blood Circulation

The liver has a unique dual blood supply, which is critical to its function:

Hepatic Portal Vein (approx. 75% of blood supply): This large vessel drains the GI tract and is rich in absorbed nutrients. This strategic location allows the liver to directly process nutrients from digestion, either storing them or transforming them into chemicals needed elsewhere in the body.
Hepatic Artery (approx. 25% of blood supply): This vessel supplies the liver with oxygen-rich arterial blood.

Terminal branches of these two vessels mix in capillary beds called sinusoids, which bathe the liver cells (hepatocytes). The blood then collects in central veins, which merge to form the hepatic vein, finally draining into the inferior vena cava.

Bile Drainage

Bile, produced by hepatocytes, is secreted into small ducts called canaliculi.
These canaliculi merge to form larger bile ducts, which eventually form the main hepatic duct.
The hepatic duct joins with the cystic duct from the gallbladder to form the common bile duct.
The common bile duct empties into the duodenum, and the flow of bile is controlled by the sphincter of Oddi.

Major Functions of the Liver

Metabolic Functions:

Glucose Metabolism: Plays a central role in maintaining blood glucose levels through processes like glycogenesis (storing glucose as glycogen), glycogenolysis (releasing glucose), and gluconeogenesis (creating glucose from non-carbohydrates).
Protein Metabolism: Synthesizes most plasma proteins, including albumin (maintains osmotic pressure) and clotting factors.
Fat Metabolism: Breaks down fatty acids for energy, synthesizes cholesterol, and produces triglycerides.
Ammonia Conversion: Converts toxic ammonia (a byproduct of protein breakdown) into urea, which is then excreted by the kidneys.

Excretory Functions:

Bile Formation: Manufactures and secretes bile, which is essential for the digestion and absorption of fats and fat-soluble vitamins in the GI tract.
Bilirubin Excretion: Breaks down old red blood cells and excretes bilirubin (a component of hemoglobin) into the bile.

Storage Functions:

Stores essential nutrients like vitamins (A, D, E, K, and B12) and minerals (iron and copper).

Detoxification/Filtration:

Drug Metabolism: Metabolizes and detoxifies drugs, alcohol, and other harmful chemicals, making them less toxic and easier to excrete.
Removes waste products and bacteria from the bloodstream.

Age-Related Changes of the Hepatobiliary System

Steady decrease in the size and weight of the liver, particularly in women.
Decrease in total blood flow to the liver.
Decreased ability for replacement and repair of liver cells after injury.
Reduced drug metabolism and a decline in drug clearance capability, increasing the risk of drug toxicity in the elderly.
Slowed clearance of hepatitis B surface antigen.
Increased prevalence of gallstones due to increased cholesterol secretion in the bile.
Decreased gallbladder contraction after a meal, which can lead to inefficient bile emptying.

DISORDERS OF THE LIVER: JAUNDICE (Hyperbilirubinemia)

Key Facts

Jaundice is a symptom, not a disease itself. It is characterized by a yellowish discoloration of the sclera (whites of the eyes) and skin.
It is caused by an abnormally high concentration of the pigment bilirubin in the blood (hyperbilirubinemia).
Bilirubin is a by-product of the normal breakdown of red blood cells. It is processed (conjugated) by the liver and then excreted into the bile.
Jaundice becomes clinically evident when the total serum bilirubin level is approximately three times the normal level (above 2 to 3 mg/dL).

Types of Jaundice

Jaundice is classified into three main types based on where the disruption in bilirubin metabolism occurs.

1. Hemolytic Jaundice (Pre-hepatic)

This type is caused by an increased breakdown of red blood cells (hemolysis), which produces an amount of unconjugated bilirubin that exceeds the liver's capacity to process it. The liver itself is functioning normally.

Causes

Blood Transfusion Reactions: Mismatched blood causes rapid destruction of transfused red blood cells.
Hemolytic Anemias: Conditions where red blood cells are destroyed prematurely, such as Sickle Cell Disease.
Sepsis / Severe Infections: Can lead to increased hemolysis.
Pregnancy-Related Conditions: HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count).
Disseminated Intravascular Coagulation (DIC): A condition causing widespread clotting and bleeding, which destroys red blood cells.

2. Hepatocellular Jaundice (Hepatic)

This type is due to the inability of damaged liver cells (hepatocytes) to clear normal amounts of bilirubin from the blood. The liver's ability to take up, conjugate, and excrete bilirubin is impaired.

Causes

Hepatitis: Viral (A, B, C), alcoholic, or autoimmune inflammation of the liver.
Drugs and Toxins: Many medications and toxins are harmful to the liver (hepatotoxic).
Alcohol: Chronic, excessive alcohol consumption is a primary cause of liver damage.
Cirrhosis: Late-stage scarring of the liver.
Liver Tumors: Primary or metastatic cancer in the liver.
Autoimmune diseases, Cholangitis, and certain herbal preparations.

3. Obstructive Jaundice (Post-hepatic)

This type results from an impeded or obstructed flow of bile through the liver or the biliary duct system. Bilirubin is conjugated by the liver but cannot be excreted into the duodenum.

Causes

The obstruction can be intrahepatic (within the liver) or extrahepatic (outside the liver).

Gallstones: A common cause, blocking the common bile duct.
Carcinoma of the Head of the Pancreas: A tumor that compresses the common bile duct.
Liver Tumors, Hepatitis, or Cirrhosis: Can cause intrahepatic obstruction.
Strictures: Narrowing of the bile ducts, often from previous surgery.
Pancreatitis: Inflammation of the pancreas can cause swelling that obstructs the bile duct.
Pressure from an Enlarged Organ.

Clinical Features of Jaundice

General Symptoms: Lack of appetite, nausea, malaise, fatigue, weakness, and weight loss.
Urine Changes: Passing of deep orange and foamy urine due to the presence of conjugated bilirubin (which is water-soluble and excreted by the kidneys).
Stool Changes: Passing of light or clay-colored stools, as bilirubin is not reaching the intestine to be converted to stercobilin (the pigment that gives stool its brown color). This is a hallmark of obstructive jaundice.
Skin Changes: Intense pruritus (itching) due to the deposit of bile salts on the skin.
GI Symptoms: Dyspepsia and intolerance to fatty foods, as bile is not available for fat digestion.

Investigations

Liver Function Tests (LFTs): To measure levels of bilirubin, liver enzymes (ALT, AST, ALP), and proteins (albumin) to assess liver function.
Hepatitis Serology: Blood tests to rule out viral hepatitis A, B, and C.
Blood Smear (BS): To rule out malaria, which can cause hemolysis.
Hemoglobin Electrophoresis: To confirm sickle cell disease.
Complete Blood Count (CBC): To assess for anemia and signs of bacterial infection.
Abdominal Ultrasound Scan: A key imaging study to visualize the liver, gallbladder, and bile ducts, and to detect gallstones or dilated ducts indicative of obstruction.
Renal Function Tests: To assess for any concurrent kidney abnormalities.
Liver Biopsy: To obtain a tissue sample to diagnose conditions like cirrhosis or liver malignancy.

Management of Jaundice

The core principle guiding the management of jaundice, a yellow discoloration of the skin, sclera (whites of the eyes), and mucous membranes due to hyperbilirubinemia, is to identify and treat the specific underlying cause of the elevated bilirubin levels. Given the diverse etiologies of jaundice (pre-hepatic, hepatic, and post-hepatic), a comprehensive diagnostic workup is essential before initiating specific treatments. Management strategies are multifaceted, encompassing supportive care, targeted interventions for the primary condition, and symptom relief.

Key Management Strategies for Jaundice

Supportive Care: This forms a crucial part of management, particularly for patients who are unwell or have impaired oral intake.

Rehydration with IV Fluids: Patients with jaundice, especially if accompanied by nausea, vomiting, or poor appetite (common in liver diseases or infections), are at risk of dehydration and electrolyte imbalances. Intravenous fluid administration is often necessary to correct these deficits, maintain hydration, and support overall physiological function.
Nutritional Support: Depending on the cause and severity, nutritional support may be needed. Patients with chronic liver disease may require dietary modifications (e.g., restricted protein in hepatic encephalopathy) or nutritional supplements.
Monitoring Vital Signs and Fluid Balance: Close monitoring helps detect signs of worsening liver function, infection, or dehydration.

Treat the Specific Underlying Cause: This is the most critical aspect of jaundice management. The approach varies widely based on the diagnosis.

Antivirals: For viral hepatitis (e.g., Hepatitis B or C) that leads to hepatic jaundice, antiviral medications are prescribed to suppress viral replication and reduce liver inflammation. Examples include Lamivudine or Adefovir (older agents for Hepatitis B), or direct-acting antivirals (DAAs) for Hepatitis C, which have revolutionized treatment for this virus.
Antibiotics: If jaundice is caused by bacterial infections, particularly those affecting the biliary tree such as cholangitis (inflammation of the bile ducts), antibiotics are crucial. Intravenous antibiotics (e.g., IV Ceftriaxone, Piperacillin-tazobactam) are often initiated promptly to control the infection and prevent sepsis.
Antimalarials: In regions where malaria is endemic, severe malaria, particularly falciparum malaria, can cause jaundice due to hemolysis and liver dysfunction. Antimalarial drugs (e.g., IV Artesunate, quinine) are administered to treat the parasitic infection.
Corticosteroids/Immunosuppressants: For autoimmune liver diseases (e.g., autoimmune hepatitis), immunosuppressive therapy with corticosteroids or other agents may be used to reduce inflammation and prevent further liver damage.
Chelating Agents/Specific Therapies: For metabolic disorders causing jaundice (e.g., Wilson's disease with copper overload, hemochromatosis with iron overload), specific therapies like chelating agents or phlebotomy are employed.
Cessation of Hepatotoxic Drugs: If drug-induced liver injury is suspected, the offending medication must be immediately discontinued.

Lifestyle Modification: These recommendations are particularly vital for patients with underlying liver disease to prevent further damage and aid recovery.

Strict Avoidance of Alcohol Intake: Alcohol is a potent hepatotoxin. For patients with any form of liver disease causing jaundice (e.g., alcoholic hepatitis, cirrhosis), complete and strict abstinence from alcohol is paramount to prevent disease progression, further liver damage, and improve prognosis.
Dietary Adjustments: Depending on the type and severity of liver dysfunction, dietary changes might be recommended (e.g., low-sodium diet for ascites, adequate protein intake unless hepatic encephalopathy is severe, avoiding raw shellfish).
Avoidance of Liver-Toxic Substances: Patients should be educated to avoid other substances known to be hepatotoxic, including certain over-the-counter medications or herbal supplements without consulting a physician.

Symptom Management: Jaundice can be accompanied by distressing symptoms that require symptomatic relief to improve patient comfort and quality of life.

Medications to Control Severe Itching (Pruritus): Elevated bilirubin and bile salts in the skin can cause intense itching. Management includes:
- Cholestyramine or Colestipol: Bile acid sequestrants that bind bile acids in the gut, preventing their reabsorption and promoting excretion.
- Antihistamines: May offer some relief, especially from associated sedative effects.
- Ursodeoxycholic Acid (UDCA): Can help improve bile flow in cholestatic conditions.
- Rifampicin or Naltrexone: Used in severe, refractory cases under specialist guidance.
- Skin care: Lukewarm baths, gentle soaps, emollients, and avoiding irritating clothing.
Pain Management: If jaundice is associated with pain (e.g., from gallstones or cholangitis).
Management of Nausea/Vomiting: Antiemetics may be prescribed.

Specific Procedures and Therapies:

Phototherapy: This treatment utilizes ultraviolet (UV) light to break down unconjugated bilirubin in the skin into water-soluble isomers that can be excreted in bile and urine without requiring conjugation in the liver. It is primarily and highly effective for neonatal jaundice, where the immature liver cannot efficiently conjugate bilirubin. It is not typically used for jaundice in adults unless specific rare conditions are present.
Surgical/Endoscopic Procedures: These are crucial for managing post-hepatic (obstructive) jaundice, where a blockage in the bile ducts prevents bile flow.
- Endoscopic Retrograde Cholangiopancreatography (ERCP): A minimally invasive endoscopic procedure used to diagnose and treat conditions of the bile ducts and pancreatic duct. It can be used to relieve biliary obstruction by:
  - Removing gallstones or common bile duct stones (choledocholithiasis).
  - Placing stents to bypass strictures or tumors in the bile ducts.
  - Taking biopsies to diagnose strictures or tumors.
- Percutaneous Transhepatic Cholangiography (PTC): An alternative to ERCP, involving a needle inserted through the skin into a bile duct, often used when ERCP is not feasible or successful, for drainage or stenting.
- Surgical Intervention: May be required to remove large or impacted gallstones, resect tumors causing obstruction (e.g., pancreatic cancer, cholangiocarcinoma), or perform reconstructive procedures on the biliary tree. For example, a cholecystectomy (gallbladder removal) is done for symptomatic cholelithiasis.
Liver Transplantation: For end-stage liver disease (e.g., from chronic hepatitis, cirrhosis, or certain genetic disorders) that has resulted in intractable jaundice and severe liver failure, liver transplantation may be the definitive treatment.

JAUNDICE (Hyperbilirubinemia) Read More »

PEPTIC ULCER DISEASE (PUD)

Nursing Notes - Peptic Ulcer Disease

PEPTIC ULCER DISEASE (PUD)

A peptic ulcer is defined as an excavation (a hollowed-out area) or an erosion that forms in the mucosal wall of the gastrointestinal (GI) tract. This lesion occurs specifically in areas that are exposed to the corrosive actions of gastric acid and the digestive enzyme pepsin. These susceptible areas typically include the stomach, the pylorus (the opening from the stomach into the duodenum), the duodenum (the first part of the small intestine), or, less commonly, the esophagus.

The naming convention for a peptic ulcer directly reflects its anatomical location: it is referred to as a gastric ulcer when located in the stomach, a duodenal ulcer when found in the duodenum, or an esophageal ulcer if it occurs in the esophagus.

Classification of Peptic Ulcers: Acute vs. Chronic

Peptic ulcers are broadly classified based on their duration and the depth of tissue involvement, primarily into acute and chronic forms. This distinction is crucial for understanding their pathology, clinical course, and treatment approaches.

Acute Peptic Ulcers

Characteristics: Acute peptic ulcers are typically associated with superficial erosion of the gastric or duodenal mucosa. This means the damage is primarily limited to the top layers of the lining, with minimal associated inflammation.
Duration and Resolution: They are generally of short duration, often developing rapidly. A key feature of acute ulcers is their tendency to resolve quickly and completely once the underlying precipitating cause or irritant is identified and effectively removed or treated. For example, an ulcer caused by a single, high dose of NSAID might be acute.
Nature of Lesion: The term "erosion" often describes an acute lesion that does not penetrate the muscularis mucosae (a thin layer of muscle in the mucosa), whereas a true ulcer penetrates this layer. Acute ulcers can still penetrate, but they are characterized by their rapid development and potential for quick healing.

Chronic Peptic Ulcers

Characteristics: Chronic peptic ulcers are characterized by their long duration and the significant depth of tissue damage. Unlike acute ulcers, they erode deeply, penetrating through the muscular wall of the GI tract. This deep erosion often leads to the formation of fibrous scar tissue during the healing process, which can sometimes result in strictures or deformities.
Clinical Course: These ulcers can persist continuously for many months, or they may manifest intermittently throughout a person's life, with periods of exacerbation and remission.
Prevalence: Epidemiologically, chronic ulcers are considerably more common than acute erosions. They are estimated to be at least four times more prevalent, highlighting their significant impact on public health and the chronicity of the disease for many individuals. The most common cause of chronic peptic ulcers is persistent infection with Helicobacter pylori (H. pylori), or the long-term, continuous use of non-steroidal anti-inflammatory drugs (NSAIDs).
Risk of Complications: Due to their depth and chronicity, chronic ulcers carry a higher risk of serious complications, including hemorrhage, perforation, and obstruction.

Etiology and Risk Factors

The development of Peptic Ulcer Disease (PUD) fundamentally arises from a critical imbalance within the gastrointestinal (GI) mucosa. This imbalance occurs between factors that aggressively attack the mucosal lining and those that provide protection. The primary aggressive factors are gastric acid and pepsin, while the key protective factors include the mucosal barrier (comprising mucus and bicarbonate production), adequate blood flow to the mucosa, and prostaglandins.

Causes and Predisposing Factors of PUD

Understanding these factors is crucial for prevention and effective management.

Helicobacter pylori (H. pylori) Infection: This gram-negative bacterium is unequivocally recognized as the leading cause of PUD globally. Approximately 80-90% of duodenal ulcers and 70-80% of gastric ulcers are attributed to H. pylori. The bacteria colonize the stomach lining, creating persistent inflammation (chronic gastritis). They disrupt the protective mucosal layer by producing enzymes (like urease, which generates ammonia, neutralizing acid locally and allowing the bacteria to survive) and toxins that directly damage gastric epithelial cells. This chronic irritation and breakdown of the mucosal defense system render the underlying tissues vulnerable to acid and pepsin.

Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs, such as aspirin, ibuprofen, naproxen, and celecoxib, are the second most common cause of PUD. Their mechanism of action involves inhibiting the production of prostaglandins. Prostaglandins are crucial for maintaining the integrity of the mucosal barrier by promoting mucus and bicarbonate secretion, maintaining mucosal blood flow, and fostering cellular repair. By blocking prostaglandin synthesis (via inhibition of cyclooxygenase enzymes, particularly COX-1), NSAIDs significantly compromise the stomach's protective mechanisms, making the mucosa susceptible to acid-pepsin induced injury and ulceration.

Lifestyle Factors: While not direct causes, these factors can exacerbate existing ulcers, impair healing, and increase susceptibility.

Excessive Smoking: Smoking is a well-established risk factor. Nicotine and other chemicals in tobacco are thought to:
- Increase gastric acid secretion.
- Reduce the production of bicarbonate, which neutralizes acid.
- Decrease prostaglandin synthesis.
- Reduce gastric mucosal blood flow, impairing healing.
- Accelerate gastric emptying, exposing the duodenum to more acid.
Excessive Alcohol Intake: Alcohol is a direct irritant to the gastric mucosa. High concentrations can cause superficial erosions and acute inflammation. Chronic heavy alcohol consumption can also impair mucosal healing and potentially contribute to the development of chronic gastritis and ulcers.
Dietary Habits: While specific foods do not cause ulcers, certain items can irritate an existing ulcer or trigger symptoms. This includes highly spicy foods, very acidic foods (e.g., citrus fruits, tomatoes), and excessive caffeine intake, which can stimulate acid secretion.

Stress:

Severe Physiological Stress: Extreme physical stress, such as that experienced during major trauma, extensive burns, severe sepsis, multiple organ failure, or significant central nervous system injury, can lead to the formation of stress ulcers (also known as Curling's ulcers in burns or Cushing's ulcers in CNS trauma). These ulcers are typically acute, superficial, and often multiple. The mechanism involves reduced mucosal blood flow (ischemia) due to sympathetic nervous system activation, increased acid secretion, and impaired mucosal defenses.
Psychological Stress: The role of psychological stress (e.g., emotional stress, anxiety) in causing PUD is less clear and remains a subject of ongoing research. While it is generally accepted that psychological stress does not directly cause ulcers, it may exacerbate symptoms in individuals with existing ulcers and potentially impair healing by affecting gastric motility, blood flow, and acid secretion.

Genetic Factors: There is evidence suggesting a genetic predisposition to PUD.

Family History: Individuals with a family history of peptic ulcers have an increased risk, suggesting a genetic component or shared environmental factors (e.g., H. pylori transmission within families).
Blood Group Association: Blood group O is more commonly associated with duodenal ulcers, while blood group A has a slight association with gastric ulcers. The exact mechanism behind these associations is not fully understood but may involve differences in susceptibility to H. pylori colonization or mucosal integrity.

Other Less Common Causes:

Zollinger-Ellison Syndrome (ZES): A rare condition characterized by a gastrin-producing tumor (gastrinoma), usually in the pancreas or duodenum. This leads to extremely high levels of gastrin, which in turn causes massive hypersecretion of gastric acid, leading to severe, multiple, and often intractable ulcers in unusual locations.
Other Medications: Certain medications, beyond NSAIDs, can also contribute, though less commonly. These include corticosteroids (when used in combination with NSAIDs), selective serotonin reuptake inhibitors (SSRIs), and some chemotherapy agents.
Chronic Medical Conditions: Conditions like Crohn's disease, chronic kidney disease, cirrhosis, and chronic obstructive pulmonary disease (COPD) have been associated with an increased risk of PUD.

Types and Clinical Features of Peptic Ulcers: Gastric vs. Duodenal

While both gastric and duodenal ulcers are types of peptic ulcers, they exhibit distinct characteristics in terms of prevalence, demographics, physiological mechanisms, and symptom patterns. Understanding these differences is crucial for accurate diagnosis and tailored treatment.

Characteristic	Gastric Ulcers (GUs)	Duodenal Ulcers (DUs)
Prevalence	Account for approximately 15-20% of all peptic ulcer cases. Less common than duodenal ulcers.	Account for the vast majority, approximately 80-85%, of all peptic ulcer cases. They are the most common type.
Age of Onset	Typically occur in an older age group, usually 50 years and older, with peak incidence between 55-65 years.	Tend to appear earlier in life, usually between 30-60 years of age, with peak incidence in the 40s.
Gender Ratio	More common in males and females equally (1:1), though some studies suggest a slight female predominance in older age.	Significantly more common in males than females (2-3:1), although the gap is narrowing.
Blood Group Association	More frequently observed in patients with blood group A.	Strongly associated with patients of blood group O.
H. pylori Association	Associated with H. pylori infection in about 70-80% of cases. NSAID use is also a significant cause.	Highly associated with H. pylori infection in about 90-95% of cases, making it the predominant cause.
Stomach Acid Secretion	Often associated with normal or even hypo-secretion (low) of stomach acid (HCl). The primary defect is often a compromised mucosal barrier rather than excessive acid.	Characteristically associated with hyper-secretion (high) of stomach acid (HCl), and often a faster rate of gastric emptying, exposing the duodenum to more acid.
Pain Pattern	Pain typically occurs relatively soon after meals, usually 30 minutes to 1 hour. Food ingestion may actually worsen the pain, leading to fear of eating and subsequent weight loss.	Pain characteristically occurs 2-3 hours after meals. It is often described as a burning or gnawing pain. A hallmark feature is that the pain is often relieved by eating food or taking antacids, as food buffers the acid. Pain frequently awakens the patient at night (between 1-2 AM) when acid secretion is high and food is absent.
Vomiting	Common, particularly after meals, and may provide temporary relief from pain. Associated with delayed gastric emptying.	Uncommon, unless complications like obstruction develop.
Weight Change	Often associated with weight loss, as patients tend to avoid eating due to post-prandial pain and nausea.	Often associated with weight gain, as patients learn that eating provides temporary relief from pain.
Hemorrhage Risk	More likely to cause hemorrhage, particularly from the lesser curvature of the stomach. Hematemesis (vomiting blood, which may look like fresh blood or "coffee grounds") is more common than melena (black, tarry stools).	While still a serious risk, they are less likely to cause major hemorrhage than gastric ulcers. If bleeding occurs, melena (black, tarry stools due to digested blood) is more common than hematemesis.
Malignancy Risk	Approximately 1-5% of gastric ulcers can be malignant (gastric cancer), making biopsy of all gastric ulcers mandatory to rule out malignancy.	Rarely associated with malignancies. Duodenal ulcers are almost always benign.

Clinical Manifestations of Uncomplicated Peptic Ulcer Disease (PUD)

The clinical presentation of PUD can vary, but certain symptoms are characteristic. It's important to note that some individuals, particularly the elderly or those on NSAIDs, may have "silent" ulcers without typical symptoms until a complication arises.

Epigastric Pain and Tenderness: This is the most common and cardinal symptom. It is often described as a burning, gnawing, aching, or hunger-like sensation located in the upper central abdomen (epigastric region). The pain can be localized or diffuse.

The timing of pain in relation to meals is a key differentiator between gastric and duodenal ulcers (as detailed in the table above).

Nausea and Vomiting: These symptoms are more common with gastric ulcers, especially if there is delayed gastric emptying or an element of gastric outlet obstruction. Vomiting may temporarily relieve pain.

Heartburn (Pyrosis) and Dyspepsia:

Heartburn: A burning sensation in the chest, often rising from the epigastrium, similar to gastroesophageal reflux disease (GERD).
Dyspepsia: A constellation of upper abdominal symptoms, including bloating, fullness, early satiety, and indigestion.

Belching, Abdominal Bloating, and Fullness: These are common non-specific symptoms that can accompany the discomfort and impaired digestion associated with PUD. Patients may feel uncomfortably full even after small meals.

Anorexia and Weight Loss: More typically seen in gastric ulcers, where eating can exacerbate pain, leading patients to avoid food.

Weight Gain: More often associated with duodenal ulcers, as patients learn that eating temporarily relieves their pain.

Investigations for PUD

Endoscopy (Esophagogastroduodenoscopy - EGD): The preferred diagnostic tool to directly visualize the ulcer, determine its size and location, and take biopsy samples.
Gastric Biopsy: To test for H. pylori (rapid urease test) and to rule out gastric malignancy, especially for gastric ulcers.
Tests for H. pylori: Urea breath test, stool antigen test, or serology (blood test for antibodies).
Barium Swallow (Upper GI Series): An X-ray study that can reveal ulcers, but is less sensitive than endoscopy.
Complete Blood Count (CBC): To assess for anemia due to chronic blood loss.
Stool Analysis: For occult blood.
Abdominal CT Scan: Used to diagnose complications like perforation or penetration.

Management of Peptic Ulcer Disease (PUD)

The comprehensive management of peptic ulcer disease is directed at several key objectives: alleviating pain, promoting the healing of the ulcer, preventing its recurrence, and diligently reducing the risk of serious complications. A patient-centered strategy, including thorough education and robust support, is paramount for achieving successful long-term outcomes.

Conservative / Non-Pharmacological Management: Foundations of Care

These interventions form the bedrock of PUD management, addressing both the underlying causes and factors that can exacerbate symptoms or impede healing.

Eradication of Helicobacter pylori (H. pylori): This is arguably the cornerstone of modern PUD treatment, especially when the ulcer is linked to this bacterial infection.

"Triple Therapy": The standard approach involves a combination of two antibiotics and a proton pump inhibitor (PPI). Common antibiotic choices include amoxicillin, clarithromycin, and metronidazole. The PPI is crucial for reducing stomach acid, creating an environment conducive to antibiotic efficacy and ulcer healing. This regimen is typically administered for 10-14 days.
"Quadruple Therapy": In cases of resistance to standard triple therapy, or in areas with high clarithromycin resistance, a quadruple therapy regimen may be employed. This usually includes a PPI, bismuth subsalicylate, and two antibiotics (e.g., metronidazole and tetracycline).
Adherence is critical: Patients must complete the full course of antibiotics to ensure successful eradication and prevent antibiotic resistance.

Lifestyle Modifications: Crucial for supporting ulcer healing and preventing recurrence.

Cessation of Smoking: Smoking is a significant impediment to ulcer healing. It reduces gastric blood flow, impairs the production of protective prostaglandins, and increases acid secretion. Patients should be strongly encouraged to quit smoking entirely.
Avoidance of Alcohol Consumption: Alcohol directly irritates the gastrointestinal (GI) mucosa and can stimulate acid secretion. Patients should be advised to abstain from alcohol or consume it only in very limited quantities.
Dietary Changes: While there's no specific "ulcer diet," patients should identify and avoid foods and beverages that cause distress. Common culprits include highly spicy foods, acidic foods (e.g., citrus, tomatoes), caffeine (coffee, tea, colas), and carbonated drinks.
- Eating smaller, more frequent meals (e.g., 5-6 small meals a day) can help neutralize acid and reduce the gastric load, potentially minimizing pain and promoting healing.
- Avoid eating large meals just before bedtime.
Stress Reduction and Rest: While stress doesn't directly cause ulcers, it can exacerbate symptoms and may impair the healing process by influencing gastric motility and acid secretion. Encouraging adequate rest, sleep, and implementing stress management techniques (e.g., meditation, yoga, deep breathing exercises) can be beneficial.

Medication Management: Focused on minimizing further gastric damage.

Reduction or Avoidance of Chronic NSAID Use: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are a major cause of peptic ulcers. If possible, patients should discontinue NSAID use.
Alternative Pain Relief: For pain management, alternatives like acetaminophen (paracetamol) should be considered.
Gastroprotective Co-prescription: If NSAIDs are absolutely necessary (e.g., for chronic inflammatory conditions), they should be co-prescribed with a proton pump inhibitor (PPI) to provide gastroprotection.

Pharmacological Treatment (Beyond H. pylori eradication):

Proton Pump Inhibitors (PPIs): (e.g., omeprazole, lansoprazole, pantoprazole, esomeprazole, rabeprazole) are the most powerful acid suppressants. They work by irreversibly blocking the proton pump in gastric parietal cells, thereby reducing acid production significantly. PPIs are essential for ulcer healing and preventing recurrence, typically prescribed for 4-8 weeks to allow complete healing.
H2-Receptor Antagonists (H2RAs): (e.g., famotidine, ranitidine - if available) reduce acid secretion by blocking histamine's action on gastric cells. Less potent than PPIs, but still effective for milder cases or as maintenance therapy.
Antacids: (e.g., aluminum hydroxide, magnesium hydroxide, calcium carbonate) provide immediate, temporary relief of ulcer pain by neutralizing existing stomach acid. They are useful for symptomatic relief but do not promote healing as effectively as PPIs or H2RAs.
Mucosal Protective Agents: (e.g., sucralfate, bismuth subsalicylate) act locally to form a protective barrier over the ulcer crater, shielding it from acid and pepsin. Sucralfate does not affect acid secretion. Bismuth also has some antibacterial properties against H. pylori.

Surgical Management: When Conservative Therapy Falls Short

Surgery for peptic ulcer disease is largely reserved for patients who experience complications unresponsive to intensive medical therapy or who present with acute, life-threatening events. Advances in pharmacological treatment, particularly the advent of PPIs and H. pylori eradication, have drastically reduced the need for surgical intervention.

Indications for Surgery:

Intractable Ulcers: Ulcers that are chronic, recurrent, and fail to heal despite adequate and prolonged medical treatment.
Hemorrhage (Bleeding): Acute, severe GI bleeding that cannot be controlled endoscopically, or recurrent bleeding despite multiple endoscopic attempts. Surgical intervention (e.g., oversewing the ulcer to ligate the bleeding vessel) may be necessary.
Perforation: A medical emergency where the ulcer erodes completely through the stomach or duodenal wall, leading to spillage of GI contents into the peritoneal cavity, causing peritonitis. Requires immediate surgical repair.
Obstruction (Gastric Outlet Obstruction): Chronic ulceration and inflammation, particularly in the pyloric region, can lead to scarring and narrowing (stenosis) that obstructs the passage of food from the stomach to the small intestine. Surgical procedures like pyloroplasty or vagotomy with gastrojejunostomy may be performed to relieve the obstruction.

Types of Surgical Procedures (Historically, and still used for complications):

Vagotomy: Severing the vagus nerve to reduce acid secretion. Can be truncal (cutting the main trunk) or selective/highly selective (cutting only branches supplying the stomach).
Pyloroplasty: Widening the pylorus (the opening from the stomach to the duodenum) to improve gastric emptying, often performed with vagotomy.
Antrectomy: Removal of the antrum (the lower part of the stomach) where gastrin is produced, often with vagotomy.
Gastrectomy: Partial or total removal of the stomach. Reserved for very severe cases or malignancy.

Nursing Management for Peptic Ulcer Disease

Nursing care for patients with PUD is comprehensive, focusing on symptom management, patient education, emotional support, and vigilant monitoring for complications. A holistic approach is essential for optimal patient outcomes.

1. Acute Pain

Related to: Erosive effects of gastric acid on the inflamed or ulcerated gastric/duodenal mucosa, muscle spasm.

Assessment:

Routinely assess and document pain characteristics: location (epigastric, radiating to back), intensity (using a 0-10 scale), quality (burning, gnawing, aching), onset, duration, and precipitating/alleviating factors (e.g., food intake, medications).
Observe for non-verbal cues of pain (restlessness, guarding, facial grimacing).
Note if pain is relieved by food (duodenal ulcer) or exacerbated by food (gastric ulcer).

Interventions:

Administer prescribed medications (PPIs, H2RAs, antacids) as ordered. Educate on proper timing (e.g., PPIs 30-60 min before meals, antacids 1-3 hours after meals and at bedtime).
Encourage small, frequent, bland meals.
Advise avoidance of known irritants (spicy foods, caffeine, alcohol, NSAIDs).
Teach and encourage non-pharmacological pain relief methods:
- Relaxation techniques (deep breathing, guided imagery, meditation).
- Application of warmth to the abdomen (e.g., warm compress or heating pad).
- Distraction techniques.
Provide a quiet and comfortable environment to promote rest and reduce stress.
Monitor effectiveness of pain interventions and adjust as needed.

2. Risk for Bleeding (Hemorrhage)

Definition: At risk for a decrease in blood volume that may compromise health.

Related to: Erosion of gastric/duodenal mucosa leading to blood vessel damage, presence of an ulcer, use of NSAIDs.

Assessment:

Monitor vital signs frequently for signs of hypovolemia: tachycardia, hypotension, weak thready pulse, tachypnea.
Assess for signs of occult or overt GI bleeding:
- Hematemesis: Bright red (fresh blood) or "coffee-ground" vomitus. Note amount, color, and frequency.
- Melena: Black, tarry, foul-smelling stools (digested blood). Assess stool color, consistency, and frequency.
- Hematochezia: Bright red blood in stool (lower GI bleed or rapid upper GI bleed).
Monitor H&H (hemoglobin and hematocrit) levels, and coagulation studies (PT/INR, PTT).
Assess for signs of shock: pallor, diaphoresis, cold clammy skin, decreased urine output, altered mental status.
Perform frequent guaiac testing of stools and gastric aspirate if nasogastric tube is in place.

Interventions:

Maintain NPO status if active bleeding is suspected or confirmed.
Establish large-bore IV access for fluid resuscitation. Administer IV fluids (crystalloids, colloids) and blood products as prescribed.
Administer IV PPIs or H2RAs as ordered to reduce acid and promote clot stability.
Prepare for and assist with endoscopic procedures (e.g., sclerotherapy, epinephrine injection, clipping) to control bleeding.
Insert and manage a nasogastric (NG) tube if ordered, for gastric lavage or aspiration.
Monitor urine output carefully as an indicator of renal perfusion.
Educate the patient and family on signs of bleeding and the importance of immediate reporting.

3. Inadequate protein energy intake

Definition: Intake of nutrients insufficient to meet metabolic needs.

Related to: Anorexia, nausea, vomiting, pain with eating, dietary restrictions, fear of pain.

Assessment:

Monitor weight, noting any significant losses.
Assess dietary intake and eating patterns; identify food intolerances or triggers.
Observe for signs of nutrient deficiencies (e.g., fatigue, poor wound healing).
Assess for nausea, vomiting, or early satiety.

Interventions:

Encourage small, frequent, bland meals that are easily digestible.
Educate the patient on dietary modifications, emphasizing foods to avoid (irritants) and foods to include (nutritious, non-acidic, non-spicy options).
Administer antiemetics as prescribed to control nausea/vomiting.
Provide good oral hygiene before and after meals to enhance appetite.
Monitor fluid and electrolyte balance, especially if vomiting is present.
Consider nutritional supplements or collaboration with a dietitian for comprehensive nutritional planning if oral intake remains inadequate.
Advise avoiding eating immediately before bedtime to reduce reflux.

4. Deficient Knowledge

Definition: Absence or deficiency of cognitive information related to specific topic.

Related to: Lack of exposure to information, misinterpretation of information, unfamiliarity with information resources.

Assessment:

Assess the patient's current understanding of PUD, its causes, treatment, potential complications, and self-care strategies.
Identify the patient's preferred learning style and readiness to learn.
Evaluate barriers to learning or adherence (e.g., health literacy, cognitive impairment).

Interventions:

Provide clear, concise, and accurate information about PUD, including:
- The nature of the disease and its common causes (especially H. pylori and NSAIDs).
- Purpose, dosage, potential side effects, and proper timing of all prescribed medications (PPIs, H2RAs, antacids, antibiotics for H. pylori). Emphasize the importance of completing antibiotic courses.
- Detailed dietary modifications (foods to avoid, recommended eating patterns).
- Importance of lifestyle changes (smoking cessation, alcohol avoidance, stress management techniques).
- Recognition of signs and symptoms of complications requiring immediate medical attention (e.g., persistent severe abdominal pain, sudden sharp pain, black tarry stools, coffee-ground emesis, persistent vomiting, fever).
Use a variety of teaching methods (verbal instruction, written materials, visual aids, teach-back method).
Encourage questions and provide ample time for discussion and clarification.
Involve family members or caregivers in the education process, as appropriate, to foster a supportive environment.
Provide reliable resources for further information and support (e.g., reputable websites, support groups).

5. Risk for Perforation or Obstruction

Definition: At risk for ulcer erosion through the gastric/duodenal wall (perforation) or narrowing due to scarring/edema (obstruction).

Related to: Deep ulceration, chronic inflammation and scarring, edema around the ulcer.

Assessment:

For Perforation: Monitor for sudden, severe, sharp abdominal pain (often described as "knife-like"), rigid, board-like abdomen, signs of peritonitis (rebound tenderness, guarding), fever, rapid shallow breathing, absent bowel sounds, signs of shock.
For Obstruction: Monitor for recurrent vomiting (especially undigested food), epigastric fullness, abdominal distention, persistent nausea, weight loss, succussion splash (sound of fluid in stomach upon shaking abdomen).

Interventions:

Report any signs or symptoms of perforation or obstruction to the physician immediately. These are medical emergencies.
Maintain NPO status if perforation or obstruction is suspected.
Prepare for emergency surgery if indicated (for perforation).
Insert and manage an NG tube for decompression in cases of obstruction or perforation.
Administer IV fluids and electrolytes as prescribed.
Monitor fluid and electrolyte balance carefully.

Complications of Peptic Ulcers

While most peptic ulcers heal with appropriate medical management, they can lead to severe and potentially life-threatening complications. Prompt recognition and management of these complications are critical.

Hemorrhage (Bleeding): This is the most common complication of PUD, occurring in about 15-20% of patients. It results from the erosion of the ulcer into a blood vessel.

Manifestations:
- Hematemesis: Vomiting of blood. It can be bright red (indicating fresh, active bleeding) or appear as "coffee grounds" (due to blood being partially digested by gastric acid). More common with gastric ulcers.
- Melena: Black, tarry, sticky, foul-smelling stools. This occurs when blood from an upper GI bleed has been digested as it passes through the intestines. More common with duodenal ulcers.
- Hematochezia: Bright red blood from the rectum. While usually indicative of lower GI bleeding, a very rapid upper GI bleed can also present with hematochezia.
Systemic Signs: Signs of significant blood loss and hypovolemia, such as pallor, dizziness, weakness, tachycardia, and hypotension.

Perforation: This is a severe and acute complication where the ulcer erodes completely through the entire wall of the stomach or duodenum, creating a hole.

Mechanism: Spillage of gastric or duodenal contents (acid, pepsin, bile, bacteria, food particles) into the sterile peritoneal cavity.
Clinical Presentation: Characterized by the sudden onset of excruciating, sharp, and generalized abdominal pain (often described as "knife-like"). The abdomen becomes rigid and board-like due to generalized peritonitis. Other signs include rebound tenderness, guarding, fever, shallow breathing, absent bowel sounds, and signs of shock.
Management: This is a surgical emergency requiring immediate intervention to close the perforation and wash out the abdominal cavity.

Penetration: This occurs when the ulcer erodes through the wall of the stomach or duodenum but into an adjacent organ (e.g., pancreas, liver, biliary tree, omentum) rather than into the free peritoneal cavity.

Clinical Presentation: The pain is often more constant, radiating to the back (if penetrating the pancreas) or other areas depending on the organ involved. It may not be relieved by food or antacids and can be more severe than typical ulcer pain.
Management: Can be difficult to manage medically and may require surgical intervention.

Pyloric Stenosis (Gastric Outlet Obstruction): This complication occurs due to chronic ulceration in or near the pyloric channel (the outlet from the stomach). Repeated cycles of inflammation, edema, spasm, and scar tissue formation cause the pyloric opening to narrow, obstructing the passage of stomach contents into the duodenum.

Clinical Presentation: Characterized by persistent and recurrent vomiting, often of undigested food ingested hours earlier. Other symptoms include epigastric fullness, abdominal distention, persistent nausea, anorexia, and progressive weight loss. A "succussion splash" (a sloshing sound heard over the stomach) may be elicited.
Management: Initial management involves gastric decompression (nasogastric tube) and correction of fluid/electrolyte imbalances. Endoscopic balloon dilation may be attempted, but surgery (e.g., pyloroplasty) may be necessary for definitive relief.

Gastric Cancer: While duodenal ulcers are almost always benign, chronic H. pylori infection is a well-established risk factor for the development of gastric adenocarcinoma and MALT (mucosa-associated lymphoid tissue) lymphoma. Therefore, any gastric ulcer, especially if not healing with treatment, requires biopsy to rule out malignancy.

Nursing Notes - Management of Severe PUD

Management of a Patient with Severe PUD

Severe Peptic Ulcer Disease, particularly with complications like hemorrhage or perforation, is a medical emergency requiring immediate intervention and comprehensive nursing care.

Aims of Management

To relieve acute signs and symptoms (e.g., pain, bleeding).
To treat and control the underlying cause.
To stabilize the patient's hemodynamic status.
To prevent further complications.

Emergency Management / Resuscitation

Maintain ABCs: Ensure a patent Airway, assess Breathing, and support Circulation. Position the patient for comfort and to prevent aspiration if vomiting.
Call for Help: Immediately notify the doctor or rapid response team about the patient's critical condition.
Establish IV Access: Secure at least one, preferably two, large-bore IV lines for rapid fluid and medication administration.
Administer IV Fluids: Start IV fluids, such as Normal Saline, to treat or prevent hypovolemic shock.
Take Blood Samples: Draw blood for urgent investigations, including CBC, cross-matching for blood transfusion, electrolytes, and coagulation studies.
Monitor Vital Signs: Take vital observations (temperature, blood pressure, pulse, respiration, and oxygen saturation) frequently (e.g., every 15-30 minutes) to monitor for signs of shock.
Control Symptoms:
- Administer IV medications to reduce gastric acid secretion (e.g., Rabeprazole 40mg or Ranitidine 150mg).
- Administer analgesics for pain relief as prescribed (e.g., IV Morphine 15mg or Pethidine 100mg). Note: NSAIDs are contraindicated.
- Administer IV antiemetics to control nausea and vomiting (e.g., Metoclopramide 10mg).
Quick Assessment: Perform a rapid assessment to establish the cause and severity of symptoms (e.g., assess for abdominal rigidity indicating perforation).
Neutralize Acid: If the patient is conscious, not actively vomiting, and there's no sign of perforation, sips of water or dairy products may be given to help neutralize stomach acids.

After the patient is stabilized, ongoing management will involve the following nursing care plan.

Nursing Care Plan

Admission

The patient is admitted to a medical or surgical ward, placed on complete bed rest, and their particulars are recorded in the ward admission book.

Psychological Care

Establish a good rapport with the patient and their relatives. Provide counseling and reassurance about the condition and treatment plan to allay anxiety.

Position

Nurse the patient in a position of comfort that ensures a patent airway and eases breathing, such as Fowler's or semi-Fowler's position, unless contraindicated by shock.

Observations

Vital Observations: Continue to monitor BP, pulse, temperature, and respiration as ordered by the doctor and record them on an observation chart.
Specific/Physical Observations: Continuously observe for:
- Abdominal discomfort, guarding, or rigidity.
- Signs of ongoing bleeding: hematemesis, melena.
- Nausea, vomiting, abdominal bloating.
- Changes in level of consciousness.
- Report the extent and severity of any findings to the doctor immediately.

Investigations

Prepare the patient for and assist with investigations as ordered by the doctor:

Blood for H. pylori test to identify the cause.
Stool analysis to rule out occult blood.
Abdominal CT scan to rule out complications like obstruction or perforation.
Barium meal to assess for structural abnormalities.

Medications / Drugs

Administer medications as prescribed and maintain an accurate treatment chart. This may include:

IV Ranitidine or Rabeprazole (PPIs).
IV antibiotics like Metronidazole.
Analgesics such as IM Pethidine alternating with IV Paracetamol.
IV fluids (e.g., Normal Saline alternating with 5% Dextrose, 2-3 litres in 24 hours).
Antacid syrups (e.g., Relcer gel) once oral intake is resumed.

Diet

The patient may be kept Nil Per Mouth (NPM) initially. Once stable, a light, well-balanced diet is introduced. Encourage plenty of oral fluids to ease digestion and neutralize stomach acids.

Hygiene

Ensure patient hygiene through daily oral care to prevent complications like stomatitis, daily bed baths, and regular turning and pressure area care to prevent pressure sores.

Elimination

Bladder Care: Offer a bedpan or urinal. Monitor urine output and maintain a fluid balance chart to assess hydration status.
Bowel Care: Offer a bedpan and observe stool for any abnormalities (e.g., melena), reporting findings to the doctor.

Exercises

Provide passive range-of-motion exercises during the recovery period. As the patient's condition improves, encourage active exercises like ambulation and deep breathing to prevent respiratory and circulatory complications.

Rest and Sleep

Ensure a quiet, restful environment by managing noise and restricting visitors. Administer medications in a timely manner to promote comfort and sleep.

Advice on Discharge

When the patient has fully improved, provide comprehensive discharge education:

Medication Compliance: Take all drugs as prescribed and complete the full course.
Diet: Eat a well-balanced diet and consume plenty of fluids, especially water and milk, to neutralize stomach acids. Eat at regular times.
Lifestyle:
- Avoid alcohol and smoking completely.
- Avoid stress and ensure adequate rest.
- Avoid chronic use of NSAIDs.
Follow-up: Return for review on the date indicated on the discharge form.

PEPTIC ULCER DISEASE (PUD) Read More »

Gastritis Lecture Notes

Nursing Notes - Gastritis

GASTRITIS

Gastritis is fundamentally an inflammation of the gastric mucosa, which is the delicate inner lining of the stomach. This inflammatory response can be widespread (diffuse) or confined to specific areas (localized) within the stomach, and it represents the body's reaction to various forms of injury or infection. Gastritis is broadly categorized into two main types based on its duration and onset: acute and chronic.

Acute Gastritis: Sudden Onset and Short-Term Inflammation

Acute gastritis is characterized by a rapid onset of inflammatory changes in the stomach lining, typically lasting for a relatively short duration—from several hours to a few days. It is frequently triggered by direct exposure to various local irritants or systemic factors.

Causes of Acute Gastritis

Dietary Indiscretion: Ingestion of foods that are irritating, excessively seasoned, very hot or cold, or contaminated with bacteria or toxins (e.g., in cases of food poisoning).
Medications: The most common culprits include the excessive or prolonged use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen. These drugs can disrupt the stomach's protective mucosal barrier.
Irritants: Significant and excessive intake of alcohol is a potent irritant that can directly damage the gastric lining.
Bile Reflux: The abnormal regurgitation of bile from the duodenum (the first part of the small intestine) back into the stomach can cause chemical irritation of the gastric mucosa.
Radiation Therapy: Therapeutic radiation directed at the abdominal area, particularly for certain cancers, can lead to direct damage and inflammation of the gastric mucosa.
Severe Physiological Stress: Extreme physical stress, such as that experienced during major surgical procedures, extensive burns, severe trauma, sepsis, multiple organ failure, or significant central nervous system (CNS) injury (e.g., head trauma), can induce stress-related erosive gastritis or stress ulcers. This is often due to reduced blood flow to the gastric lining.
Chemicals: Accidental or intentional ingestion of strong corrosive agents like acids or alkalis can lead to severe mucosal injury, potentially causing the lining to become gangrenous (tissue death) or even perforate (form a hole).
Systemic Infections: In some cases, acute gastritis can be an early or accompanying symptom of a broader systemic infection, such as viral infections (e.g., norovirus, rotavirus) or bacterial infections elsewhere in the body.
Acute Viral or Bacterial Infections of the Stomach: Infections directly affecting the stomach lining, often leading to gastroenteritis (inflammation of both stomach and intestines).

Clinical Manifestations of Acute Gastritis

The symptoms of acute gastritis usually appear suddenly and can range in severity:

Onset of symptoms is often rapid and can be quite distressing.
Abdominal Discomfort or Cramping: A general feeling of unease or colicky pain in the upper abdomen.
Epigastric Pain or Tenderness: Localized pain or sensitivity in the upper central part of the abdomen, just below the breastbone.
Headache and Lassitude: Generalized fatigue, weakness, and headache can accompany the gastric symptoms, especially in more severe cases or with systemic causes.
Nausea and Vomiting: Common symptoms, with vomiting often providing temporary relief. The vomitus may contain food, bile, or even streaks of blood.
Anorexia: A significant loss of appetite due to discomfort and nausea.
Hiccupping: Persistent hiccups can occur due to irritation of the diaphragm.
Diarrhea: May be present, especially if the cause is food poisoning or a systemic infection affecting the intestines as well.
Painless GI Bleeding: This is a serious potential complication, particularly in individuals who have consumed large amounts of alcohol or are regular users of aspirin and NSAIDs. Bleeding can manifest as hematemesis (vomiting blood, which may look like "coffee grounds") or melena (black, tarry stools due to digested blood).

Chronic Gastritis

Chronic gastritis is characterized by prolonged inflammation of the stomach lining, often leading to structural changes in the mucosa over time, such as glandular atrophy (wasting away of the glands) or metaplasia (change in cell type). Unlike acute gastritis, its onset can be insidious, and symptoms may be less severe but persistent or intermittent. It may be caused by benign or malignant ulcers, but the most prevalent cause is a specific bacterial infection.

Causes of Chronic Gastritis

Bacterial Infection: The single most common cause worldwide is chronic infection with the bacterium Helicobacter pylori (H. pylori). This bacterium colonizes the stomach lining and causes ongoing inflammation, which can progress to atrophy and increase the risk of peptic ulcers and gastric cancer.
Autoimmune Diseases: In some cases, the body's immune system mistakenly attacks its own stomach cells. A notable example is autoimmune gastritis, which is strongly associated with pernicious anemia, where the immune system destroys parietal cells responsible for producing intrinsic factor (necessary for Vitamin B12 absorption).
Dietary Factors: Chronic and excessive intake of certain irritants, such as large amounts of caffeine or highly processed foods, can contribute to chronic inflammation over time.
Chronic Medication Use: Long-term, regular use of NSAIDs is a significant contributor to chronic gastritis, similar to acute forms, but with persistent damage.
Lifestyle Factors: Chronic and excessive alcohol consumption and smoking are well-established risk factors that cause persistent irritation and impair the stomach's protective mechanisms.
Chronic Reflux: Persistent and significant reflux of bile and pancreatic secretions from the duodenum into the stomach can lead to ongoing chemical irritation and chronic inflammation. This is often seen after certain types of gastric surgery (e.g., gastrectomy).
Recurring Episodes of Untreated Acute Gastritis: If acute gastritis episodes are frequent, severe, or inadequately managed, the persistent irritation can eventually lead to chronic changes in the gastric mucosa.
Granulomatous Conditions: Rarer causes include inflammatory conditions like Crohn's disease or sarcoidosis that can affect the stomach.

Clinical Manifestations of Chronic Gastritis

The symptoms of chronic gastritis can be less dramatic than acute forms and may even be subtle or absent for extended periods:

May be Asymptomatic: Many individuals with chronic gastritis, especially those with H. pylori infection, may experience no symptoms for years, or only vague digestive discomfort.
Anorexia: A persistent or intermittent loss of appetite.
Heartburn: A burning sensation in the chest, particularly after eating, similar to indigestion.
Belching or a Sour Taste in the Mouth: Frequent burping and a persistent unpleasant, sour, or metallic taste can be present due to impaired digestion or reflux.
Nausea and Vomiting: These symptoms can occur intermittently, usually less severe than in acute gastritis.
Malabsorption of Vitamin B12: This is a crucial manifestation of autoimmune gastritis or advanced H. pylori-induced atrophic gastritis. Chronic inflammation, particularly when leading to atrophy of parietal cells, can significantly reduce the production of intrinsic factor. Intrinsic factor is essential for the absorption of dietary vitamin B12 in the small intestine. This malabsorption can lead to pernicious anemia (a type of megaloblastic anemia) and neurological complications if left untreated.
Feeling of Fullness: A sensation of feeling full very quickly after starting a meal (early satiety).
Epigastric Discomfort: Vague, dull ache or discomfort in the upper abdomen, often worse after meals.

Investigations for Gastritis

Accurate diagnosis of gastritis, and more importantly, its underlying cause, is crucial for effective treatment and preventing complications. A combination of clinical assessment and specific diagnostic tests is usually employed.

Endoscopy (Esophagogastroduodenoscopy - EGD): This is considered the gold standard for confirming the diagnosis of gastritis.

Visualization: A thin, flexible tube with a camera is inserted through the mouth to directly visualize the gastric mucosa, allowing the clinician to observe the extent and characteristics of the inflammation (e.g., redness, erosions, atrophy).
Biopsy: During endoscopy, small tissue samples (biopsies) can be taken from the stomach lining. These samples are then sent for histopathological examination.

Stomach Biopsy (Histopathological Examination): This is a critical component of the diagnostic process.

Confirmation of Gastritis: The biopsy confirms the presence of inflammation and helps to differentiate between acute and chronic forms.
Rule out Malignancy: It is essential for ruling out dysplastic changes or gastric malignancy, especially in cases of chronic gastritis or suspicious lesions.
Identify Histological Changes: It can identify specific features like glandular atrophy, intestinal metaplasia, and the presence of H. pylori.

Tests for Helicobacter pylori (H. pylori): Given its prevalence as a cause of chronic gastritis, testing for H. pylori is standard.

Urea Breath Test: A non-invasive test where the patient ingests a urea-containing tablet. If H. pylori is present, it breaks down the urea, releasing carbon dioxide that can be detected in the breath.
Stool Antigen Test: A non-invasive test that detects H. pylori antigens in a stool sample.
Blood Test (Serology): Detects antibodies to H. pylori. While indicating past exposure, it cannot differentiate between active infection and successfully treated infection.
Biopsy-based Tests: Rapid Urease Test (RUT) on a biopsy sample obtained during endoscopy, or histological examination of the biopsy itself.

Barium Meal (Upper GI Series / Barium Swallow): This is an X-ray study that can help evaluate the structure and function of the upper gastrointestinal tract.

Visualization: After ingesting a barium-containing liquid, X-ray images are taken to outline the esophagus, stomach, and duodenum.
Evaluation for Complications: While less sensitive for diagnosing gastritis itself than endoscopy, it can help identify complications such as structural abnormalities (e.g., strictures), severe ulcerations, or signs of perforations. It is generally used when endoscopy is not available or contraindicated.

Stool Analysis:

Occult Blood Test: To check for hidden (occult) blood in the stool. A positive result indicates gastrointestinal bleeding, which can occur in both acute and chronic gastritis, especially erosive forms or if ulcers are present.

Blood Tests:

Complete Blood Count (CBC): To check for anemia (especially iron deficiency anemia due to chronic blood loss or pernicious anemia due to B12 malabsorption).
Vitamin B12 Levels: Crucial in suspected autoimmune gastritis to assess for pernicious anemia.
Electrolyte Levels: Especially if there is significant vomiting.

Management of Gastritis

The effective management of gastritis is multifaceted, encompassing both non-pharmacological and pharmacological strategies. The primary goals are to identify and eliminate the causative agents, alleviate symptoms, promote healing of the gastric mucosa, and prevent recurrence and complications. A patient-centered approach, including education and support, is crucial for successful outcomes.

Non-Pharmacological Management: Lifestyle and Dietary Modifications

These interventions are foundational to gastritis management and often provide significant relief, particularly in mild to moderate cases.

Dietary Changes: Tailoring the diet to minimize irritation and promote healing. Avoidance of Irritants: Strictly avoid foods and beverages known to irritate the stomach lining. This commonly includes:

Spicy foods (e.g., chilies, hot sauces)
Acidic foods and beverages (e.g., citrus fruits and juices, tomatoes, vinegar)
Carbonated drinks
Caffeine (coffee, tea, energy drinks)
Alcohol (a direct gastric irritant)
Fatty and fried foods (can delay gastric emptying and increase acid production)
Certain dairy products (for some individuals)

Eating Habits:

Smaller, More Frequent Meals: Instead of three large meals, encourage 5-6 smaller meals throughout the day. This helps to maintain a consistent stomach environment and avoids overfilling the stomach, which can stimulate excessive acid secretion.
Regular Meal Times: Eating at consistent times helps regulate digestive processes and acid production.
Eat Slowly and Chew Thoroughly: Aids digestion and reduces the amount of air swallowed.
Avoid Eating Before Bed: Do not eat for at least 2-3 hours before lying down to prevent reflux and nocturnal acid secretion.

Recommended Foods: Focus on easily digestible, bland foods.

Lean proteins (baked chicken, fish)
Non-acidic fruits (apples, bananas, pears)
Cooked vegetables (steamed, boiled)
Whole grains (oatmeal, brown rice)
Low-fat dairy (if tolerated)

Lifestyle Modification: Addressing habits and external factors that contribute to gastritis.

Avoidance of Smoking and Alcohol Intake: Both are direct irritants to the gastric mucosa and impair healing. Smoking also reduces blood flow to the stomach lining.
Avoidance of Chronic Use of NSAIDs: Non-Steroidal Anti-Inflammatory Drugs (e.g., ibuprofen, naproxen, aspirin) are a very common cause of gastritis and peptic ulcers. If pain relief is needed, acetaminophen (Paracetamol) is generally preferred. If NSAIDs are unavoidable, they should be taken with food and possibly with a gastroprotective agent (like a PPI).
Stress Reduction and Management Techniques: Psychological stress can exacerbate gastritis symptoms by influencing gastric acid secretion and motility. Techniques include:
- Mindfulness and meditation
- Deep breathing exercises
- Yoga or Tai Chi
- Regular physical activity (non-strenuous)
- Adequate sleep
- Seeking support from counseling or therapy if stress is severe.
Weight Management: If overweight or obese, losing weight can help reduce pressure on the abdomen and lessen reflux symptoms, which can sometimes contribute to gastritis.

Pharmacological Treatment: Targeting Acid and Infection

Medications are often necessary to reduce stomach acid, protect the gastric lining, and eradicate infections.

Antacids: Provide immediate, temporary relief by neutralizing existing stomach acid.

Mechanism: Act as weak bases that directly react with hydrochloric acid in the stomach.
Examples: Magnesium Trisilicate (tablets or suspensions), Aluminum Hydroxide/Magnesium Hydroxide combinations (e.g., Relcer gel, Ulgel, Maalox).
Dosage: Typically 10-20mL or 1-2 tablets taken 30 minutes to 1 hour after meals and at bedtime.
Considerations: Magnesium-containing antacids can cause diarrhea; aluminum-containing antacids can cause constipation. Combinations help balance these effects.

H2-Receptor Antagonists (H2RAs): Reduce acid production by blocking histamine's action on parietal cells.

Mechanism: Block H2 receptors on gastric parietal cells, leading to decreased histamine-stimulated acid secretion.
Examples: Ranitidine (150mg), Famotidine (20mg, 40mg), Cimetidine (less commonly used due to drug interactions).
Dosage: Usually taken once or twice daily, depending on the severity of symptoms.
Considerations: Generally well-tolerated; available over-the-counter and by prescription. Provide longer-lasting acid control than antacids.

Proton Pump Inhibitors (PPIs): The most potent acid suppressants.

Mechanism: Irreversibly block the H+/K+-ATPase pump (proton pump) in gastric parietal cells, effectively shutting down acid production.
Examples: Omeprazole (20mg, 40mg), Rabeprazole (20mg), Lansoprazole (15mg, 30mg), Pantoprazole (20mg, 40mg), Esomeprazole (20mg, 40mg).
Dosage: Typically taken once daily, 30-60 minutes before the first meal of the day for maximal effect.
Considerations: Highly effective for healing and preventing recurrence. Long-term use requires monitoring due to potential side effects (e.g., increased risk of C. difficile infection, bone fractures, nutrient malabsorption).

Supportive Therapy

Analgesics: For pain relief, especially during acute flares.

Paracetamol (Acetaminophen): Generally preferred over NSAIDs for pain management in gastritis patients due to its lower risk of gastric irritation. Dosage typically 500mg or 1g orally three times daily for 3-5 days, or as prescribed, ensuring daily maximum dose is not exceeded.
Avoid NSAIDs: Unless absolutely necessary and with gastroprotective co-medication.

Prokinetic Agents: (Less commonly used specifically for gastritis, but may be considered if delayed gastric emptying contributes to symptoms).

Mechanism: Improve gastric motility and emptying.
Examples: Metoclopramide, Domperidone.
Considerations: Potential for side effects (e.g., neurological for metoclopramide).

Mucosal Protective Agents:

Sucralfate: Forms a protective barrier over the ulcerated or inflamed mucosa, shielding it from acid and enzymes. Does not alter acid secretion.
Bismuth Subsalicylate: Has some mucosal protective properties and also antibacterial effects against H. pylori.

NOTE: If the cause of gastritis is confirmed to be Helicobacter pylori (H. pylori) bacteria, eradication therapy is essential to prevent recurrence and complications like peptic ulcers and gastric cancer. Treatment typically involves a combination therapy, known as "triple therapy" or "quadruple therapy":

Triple Therapy: Usually comprises one PPI and two antibiotics for 10-14 days.

Common Regimen: PPI (e.g., Omeprazole 20mg twice daily) + Clarithromycin (500mg twice daily) + Amoxicillin (1000mg twice daily).
Alternative (if penicillin allergy): PPI + Clarithromycin + Metronidazole (400-500mg twice daily).

Quadruple Therapy: Increasingly used due to rising clarithromycin resistance, this includes one PPI, bismuth, and two antibiotics.

Common Regimen: PPI + Bismuth + Metronidazole + Tetracycline.

Considerations for H. pylori Eradication:

Strict adherence to the medication regimen is crucial for successful eradication and to prevent antibiotic resistance.
Side effects (nausea, diarrhea, metallic taste) are common with antibiotic combinations.
Follow-up testing (urea breath test, stool antigen test) is recommended 4-6 weeks after completing therapy to confirm eradication.

Nursing Diagnoses and Interventions for Gastritis

Nursing care for patients with gastritis focuses on symptom management, patient education, emotional support, and monitoring for complications. Here are common nursing diagnoses and associated interventions:

1. Acute Pain

Definition: Unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage; sudden or slow onset of any intensity from mild to severe with an anticipated or predictable end.
Related to: Irritated gastric mucosa, increased gastric acid secretion, inflammation.
Assessment:

Monitor pain characteristics (location, intensity, quality, duration) using a pain scale (e.g., 0-10).
Observe non-verbal cues of pain (restlessness, grimacing, guarding).
Assess factors that aggravate or relieve pain.

Interventions:

Administer prescribed analgesics (e.g., Paracetamol) as ordered, and evaluate effectiveness.
Administer antacids, H2RAs, or PPIs as prescribed; educate on proper timing (e.g., PPIs before meals, antacids after meals).
Teach and encourage non-pharmacological pain relief methods:
- Applying warm compresses to the abdomen.
- Relaxation techniques (deep breathing, guided imagery).
- Distraction.
Encourage small, frequent, bland meals.
Avoid known gastric irritants (spicy food, caffeine, alcohol, NSAIDs).
Provide a quiet and comfortable environment.

2. Inadequate protein energy intake

Definition: Intake of nutrients insufficient to meet metabolic needs.
Related to: Anorexia, nausea, vomiting, pain experienced with eating, dietary restrictions.
Assessment:

Monitor weight, noting any losses.
Assess dietary intake and eating patterns.
Observe for signs of nutrient deficiencies.
Note presence of nausea, vomiting, or early satiety.

Interventions:

Encourage consumption of small, frequent meals of bland, easily digestible foods.
Educate patient on foods to avoid (irritants) and foods to favor.
Administer antiemetics as prescribed if nausea/vomiting is significant.
Provide oral hygiene before and after meals to enhance appetite.
Monitor fluid and electrolyte balance, especially if vomiting.
Consider nutritional supplements if oral intake remains poor.
Collaborate with a dietitian for comprehensive nutritional planning.

3. Deficient Knowledge

Definition: Absence or deficiency of cognitive information related to specific topic.

Related to: Lack of exposure, misinterpretation of information, unfamiliarity with information resources.

Assessment:

Assess patient's current understanding of gastritis, its causes, management, and prevention.
Identify learning style and readiness to learn.
Evaluate patient's ability to adhere to treatment regimen.

Interventions:

Provide clear, concise, and accurate information about gastritis, including:
- Nature of the disease and its common causes (e.g., H. pylori, NSAIDs, stress).
- Purpose, dosage, side effects, and proper timing of all prescribed medications (antacids, H2RAs, PPIs, antibiotics).
- Importance of adhering to the full course of H. pylori eradication therapy if applicable.
- Detailed dietary modifications (foods to avoid, foods to include, meal timing).
- Importance of lifestyle changes (smoking cessation, alcohol avoidance, stress management).
- Signs and symptoms of complications requiring immediate medical attention (e.g., severe abdominal pain, persistent vomiting, black tarry stools, coffee-ground emesis).
Use various teaching methods (verbal instruction, written materials, visual aids).
Encourage questions and allow time for discussion.
Involve family members or caregivers in the education process as appropriate.
Provide resources for further information and support.

4. Risk for Fluid Volume Deficit

Definition: At risk for experiencing a decrease in intravascular, interstitial, and/or intracellular fluid.

Related to: Nausea, vomiting, decreased oral intake due to pain, gastric bleeding (if present).

Assessment:

Monitor intake and output.
Assess skin turgor, mucous membranes, and urine specific gravity.
Monitor vital signs (tachycardia, hypotension, weak pulse).
Observe for signs of dehydration (thirst, dizziness, decreased urine output).
Monitor laboratory values (electrolytes, BUN, creatinine, hemoglobin, hematocrit).

Interventions:

Encourage frequent sips of clear fluids (water, clear broths, diluted juices) if tolerated.
Administer intravenous fluids as prescribed if oral intake is insufficient or if dehydration is present.
Administer antiemetics to control nausea and vomiting.
Monitor for signs of GI bleeding (hematemesis, melena) and report immediately.
Educate patient on importance of hydration.

5. Nausea

Definition: A subjective unpleasant sensation of sickness with a feeling in the back of the throat and stomach that may or may not result in vomiting.

Related to: Gastric irritation, inflammation, delayed gastric emptying, medication side effects.

Assessment:

Assess the intensity and frequency of nausea.
Note any precipitating or alleviating factors.
Observe for associated symptoms like vomiting, excessive salivation, pallor, or sweating.

Interventions:

Administer antiemetics as prescribed.
Offer small, frequent, bland meals.
Avoid strong odors (food, perfumes) that might trigger nausea.
Encourage patient to rest in a comfortable position.
Provide good oral hygiene.
Suggest sipping on clear, cold liquids (e.g., ginger ale, clear broth).
Educate on dietary modifications to reduce nausea.

Gastritis Lecture Notes Read More »

nursesrevision@gmail.com

Teaching Methodology Quiz

Past Papers Review

Teaching Methodology

Assessment Complete!

IMNCI Cumulative Quiz

Integrated Management of Childhood Illness

IMNCI Cumulative Quiz

Assessment Complete!

IMNCI Identify Treatment Quiz

Integrated Management of Childhood Illness

IMNCI Treatment

Assessment Complete!

IMNCI Session One Cont. Assessment

Integrated Management of Childhood Illness

IMNCI Session One

Assessment Complete!

IMNCI Session One Quiz

Integrated Management of Childhood Illness

IMNCI Session One

Assessment Complete!

CHOLECYSTITIS

Causes

Clinical Features of Cholecystitis

Classification of Acute Cholecystitis

Investigations

Complications of Acute Cholecystitis

Management of Cholecystitis

Conservative Management (Medical)

Aims of Medical Management

Interventions

Surgical Management

Nursing Diagnoses and Interventions for Cholecystitis

1. Acute Pain

2. Nausea and Vomiting

3. Deficient Fluid Volume / Risk for Deficient Fluid Volume

4. Risk for Infection (or Imbalanced Body Temperature: Hyperthermia)

5. Knowledge Deficit

LIVER CIRRHOSIS

Types of Liver Cirrhosis

Causes of Liver Cirrhosis

Clinical Features of Liver Cirrhosis

Compensated Cirrhosis

Decompensated Cirrhosis

Investigations for Liver Cirrhosis

Management of a Patient with Liver Cirrhosis

Aims of Management

Nursing Care Plan for Patients with Liver Cirrhosis

1. Admission and Initial Assessment

2. Ongoing Monitoring and Observations

3. Diagnostic Investigations

4. Pharmacological Management

5. Non-Pharmacological Management & Lifestyle Modifications

6. Surgical Treatment and Procedures

7. Elimination Management

8. Hygiene and Skin Care

9. Activity and Mobility

10. Discharge Planning and Education

Complications of Liver Cirrhosis

Nursing Diagnoses and Interventions for Liver Cirrhosis

1. Excess Fluid Volume

2. Inadquate protein energy intake

3. Risk for Bleeding

4. Altered Thought Processes / Risk for Acute Confusion

5. Impaired Skin Integrity / Risk for Impaired Skin Integrity

6. Risk for Infection

7. Activity Intolerance

Disorders of the Biliary System

Review of Liver Disorders

Anatomy and Physiology of the Liver

Location and Structure

Blood Circulation

Bile Drainage

Major Functions of the Liver

Age-Related Changes of the Hepatobiliary System

DISORDERS OF THE LIVER: JAUNDICE (Hyperbilirubinemia)

Key Facts

Types of Jaundice

1. Hemolytic Jaundice (Pre-hepatic)

Causes